Jean de la Rosette, MD

Transcription

Jean de la Rosette, MD
Dr de la Rosette is Professor and Chairman of the Department of Urology, at AMC
University Hospital in Amsterdam, the Netherlands. He completed his medical degree
and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands.
He subsequently was appointed consultant urologist and Director Minimal Invasive
Urology at the Department of Urology at the St Radboud University Hospital in
Nijmegen.
Dr de la Rosette is the chairman of the committee on Minimal Invasive Treatment of
Benign Prostatic Hyperplasia (BPH) of the International Consultation on BPH. He is also
chairman of the committee on Renal Stone Disease of the International Consultation on
Stone Diseases. Both consultations are patronised by the World Health Organisation
(WHO). He is chairman of the European Society of Uro-Technology (ESUT) and board
member of the Society of Endourology. He is a member of the executive board of the
Société International d’Urologie (SIU). Dr. de la Rosette was chairman of the European
Association of Urology (EAU) working party on BPH guidelines.
Dr de la Rosette is author of over 400 peer reviewed publications and has authored
many book chapters. He is the editor of books in the field of laparoscopy, renal
carcinoma, prostate diseases, urological imaging and voiding dysfunction. He is also on
the editorial board of the Journal of Endourology, the Journal of Urology, BJU
International, the Central European Journal of Urology and European Urology. Dr de la
Rosette is a member of various urological societies: e.g. the International Continence
Society (ICS), the American Urological Association (AUA), the European Association of
Urology (EAU) and the Société International d’Urologie (SIU).
He is strongly committed to research and has been appointed as chairman of the CROES
(Clinical Research Office of the Endourology Society). Dr. de la Rosette is the scientific
chairman of the World Congress on Endourology 2012. He furthermore organizes the
Challenges in Endourology meeting and the annual symposium on Focal Therapy and
Imaging in Prostate and Kidney Cancer.
CURRICULUM VITAE
PERSONALIA:
Name
First name
Born
Name spouse
Home address
Work address
Telephone private
Mobile phone
Telephone at work
Fax at work
E-mail
de la Rosette
Jean
25 November 1957 at Heerlen, the Netherlands
Laguna, Pilar
Casparuslaan 511
1382 KR Weesp
The Netherlands
Academic Medical Center, Department of Urology
Meibergdreef 9
1105 AZ Amsterdam
The Netherlands
+31(0)294–772010
+31(0)6–535 38 846
+31(0)20–566 60 30
+31(0)20–566 95 85
j.j.delaRosette@amc.uva.nl
TRAINING AND CURRENT POSITION:
1977
Medical study University Nijmegen, the Netherlands
1985
MD and start residency
1992
Consultant urologist and Director Minimal Invasive Urology, Department of
Urology, University Hospital Nijmegen, the Netherlands
1994
PhD thesis
2002
Professor and Chairman of the Department of Urology, Academic Medical
Center and University of Amsterdam, the Netherlands
MEMBERSHIP:
International Continence Society (ICS)
Nederlandse Vereniging voor Urologie (NVU)
Deutsche Gesellschaft für Urologie (DGU)
American Urological Association (AUA)
European Association of Urology (EAU)
Société International d‟Urologie (SIU)
Society of Endourology
OTHER ACTIVITIES:
Chairman Clinical Research Office of the Endourological Society (CROES)
Member WHO committee on minimal invasive treatment of BPH
Boardmember and past chairman European Society of Uro-Technology (ESUT)
Member and past chairman EAU working party on BPH guidelines
Member executive board Société International d‟Urologie (SIU)
Assistant Editor Journal of Endourology
Member at large - Editorial Board European Urology
Member Board of directors Society of Endourology
Editorial Board Member European Urological Review
Curriculum Vitae
2
J. de la Rosette
INTERNATIONAL ACTIVITES
President WCE 2005 meeting
Scientific Chairman WCE 2012 meeting
Co-director Meeting on Focal Therapies June 6-8th 2012
Co-director Challenges in Endourology June 27-29th 2012
ASSISTANT/ASSOCIATE EDITOR
Journal of Endourology
Journal of Urology
BJU International
Journal of Central Europe
Turkish Journal of Urology
European Urology
Advances in Urology
CO-PROMOTER PHD THESIS:
1.
dr.ir. R. Giesen: Beyond ultrasonographic imaging of the prostate – computer analysis
and cancer detection (may 16th 1995).
2.
dr. P.F.W.M. Rosier: Bladder function in elderly male patients (February 27th 1996).
3.
dr.ir. A. Huijnen: Automated interpretation of ultrasonographic prostate images
(March 29th 1996).
4.
dr. K. Ezz El Din: Benign Prostatic Hyperplasia – clinical assessment and evaluation
(June 24th 1996).
5.
dr.ir. R.G. Aarnink: Automated contour detection – design and clinical applications
in urology (September 10th 1996).
6.
dr. M.J.A.M de Wildt: Transuretheral Microwave Thermotherapy – an evolving
technology in the treatment of benign prostatic enlargement (September 24th 1996).
7.
dr. W.P.J. Witjes: Micturation variables in the assessment and treatment of patients
with lower urinary tract symptoms (May 21th 1997).
8.
dr. E. te Slaa: Laser prostatectomy in the treatment of benign prostatic obstruction
(May 27th 1997).
9.
dr. Y. Xue: Cell Biological Aspects of Prostate Development and Disease (May 18th
1998).
10.
dr. F.C.H. d’Ancona: Selection Criteria for High Energy TransUrethral Microwave
Thermotherapy of the Prostate (January 27th 1999).
11.
dr. H.P. Beerlage: New aspects in diagnosis and minimal invasive treatment of prostate
cancer (November 29th 1999).
12.
dr. B.S.S. Wadie: Objective Evaluation of Prostatic symptoms, a Prospective study
(January 2000).
13.
dr. G. Sonke: Principles of Diagnostic Research Applied to Lower Urinary Tract
Symptoms (June 21st 2000).
Curriculum Vitae
3
J. de la Rosette
14.
dr. B.B.M. Kortman: Critical Evaluation of Urodynamic Studies in the Assessment and
Treatment of Men with Lower Urinary Tract Symptoms (June 8th 2001).
15.
dr. D. Floratos: Efficiancy assessment of Minimally Invasive Therapies for the
management of BPH (May 14th 2001).
dr. J.P.M. Sedelaar: Contrast ultrasonography in the detection and follow up of
prostate cancer (February 7th 2002).
16.
17.
dr. E.A.E. Francisca: Evaluation of TransUrethral Microwave Thermotherapy for
Benign Prostatic Enlargement (February 21st 2002).
PROMOTER PHD THESIS:
1.
dr. C.A. Mochtar: prognostic factors for clinical progression after treatment of BPH.
(April 4th 2006).
2.
dr. S. Gravas: TUMT treatment of BPH: from evidence based guidelines to clinical
practice (April 20th 2007).
3.
dr. S.I. Langbein: Urothelial Carcinoma of the Urinary Tract: molecular analyses for
clinical applications (September 28th 2007).
4.
dr. M.M. Barendrecht: Bladder outlet obstruction and hypertrophy: mechanisms and
consequences (November 21st 2008).
5.
dr. M.M. van Dijk: Balancing clinical outcomes and quality of life aspects in the
treatment of LUTS/BPH (January 22nd 2010).
6.
dr.I.Kümmerlin: Renal Tumours in the Netherlands: A Decade of Pathology and a Plea
for Biopsy (November 11th 2010).
7.
dr.G.P. Haber: Application of Emerging Technologies to Urologic Oncology
(November 16th 2010)
8.
dr. E.C.C. Cauberg: Advancements in diagnostic imaging for urothelial carcinoma
(October 12th 2011)
9.
dr. P. Beemster: Defining the position of cryoablation in the therapeutic
armamentarium of small renal masses (January 11th 2012)
10.
dr. O.K.. Zaki Mahmoud: Facing challenges in penile prosthesis implantation
(February 2nd 2012)
CO-EDITOR BOOKS:
1.
J.J.M.C.H. de la Rosette, I. Gill. Laparsocopic Urologic Surgery in Malignancies.
Heidelberg: Springer 2005.
2.
J.J.M.C.H. de la Rosette, H. Van Poppel, C. Sternberg. Renal Cell Cancer:
Diagnosis and Therapy. Springer-Verlag London Limited 2008.
3.
J.J.M.C.H. de la Rosette, M. Harisinghani, M. Manyak, H. Wijkstra. Imaging in
Oncological Urology. Springer-Verlag London Limited 2009.
Curriculum Vitae
4
J. de la Rosette
4.
G.H. Badlani, G.W. Davila, M.C. Michel, J.J.M.C.H. de la Rosette. Continence in
males and females. Current concepts and treatment strategies. Springer-Verlag
London Limited 2009.
5.
A. Bachmann and J.J.M.C.H. de la Rosette. Benign Prostatic Hyperplasia and
Lower Urinary Tract Symptoms in Men. Oxford University Press 2012 (in press).
PUBLICATIONS (peer reviewed)
1990:
1.
J.J.M.C.H. de la Rosette and F.M.J. Debruyne. Extragonadal germ cell tumor
invading the prostate. Eur Urol. 1990; 18: 77-79.
2.
A.J.M. Hendrikx, J.J.M.C.H. de la Rosette, C.A.M. van Helvoort-van Dommelen,
M.A.A.M. van Dijk, H. Semmelink, N.V.M. Rijntjes and F.M.J. Debruyne. Histologic
analysis of ultrasonic images of the prostate: an accurate technique. Ultrasound in
Med & Biol 1990; 16(7): 667-674.
1991:
3.
J.J.M.C.H. de la Rosette, J.D.M. de Vries, M.T.W.T. Lock, F.M.J. Debruyne.
Urethra plasty using the pedicled island flap technique in complicated urethral
strictures. J Urol.1991; 146:40-42.
4.
J.J.M.C.H. de la Rosette and F.M.J. Debruyne. Non-bacterial prostatitis: a comprehensive review. Urol Int. 1991; 46:121-125.
1992:
5.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, F.M.J. Debruyne. Ultrasonographic
findings in patients with non-bacterial prostatitis. Urol Int. 1992; 48: 323-326.
6.
J.J.M.C.H. de la Rosette, M.R. Hubregtse, H.F.M. Karthaus, F.M.J. Debruyne.
Results of a questionnaire among dutch urologists and general practitioners
concerning diagnostics and results of treatment of patients with prostatitis
syndromes. Eur Urol. 1992; 22: 14-18.
7.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, Ph.E.V.A. van Kerrebroeck, Th. de
Boo, F.M.J. Debruyne. The use of alfuzosin, a new alpha receptor blocking agent, in
patients with prostatodynia and voiding symptoms of an irritative nature. Urology
1992. 9: 215-219.
8.
H.P. Beerlage, J.J.M.C.H. de la Rosette, A.J. Frima. Association between
haematoma after inguinal hernia repair and site of heparin injection. Eur J Surg.
1992; 158 :287-288.
9.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, Ph.E.V.A. van Kerrebroeck, Th. de
Boo, F.M.J. Debruyne. Research in “prostatitis syndromes”: the use of alfuzosin (a
new alpha-1-receptor blocking agent) in patients mainly presenting with micturition
Curriculum Vitae
5
J. de la Rosette
complaints of an irritative nature and confirmed urodynamic abnormalities. Eur
Urol. 1992; 22(3): 222-227.
1993:
10.
J.J.M.C.H. de la Rosette, M.R. Hubregtse, E.J.H. Meuleman, M.V.M. StolkEngelaar, F.M.J. Debruyne. Diagnostics and treatment of 409 patients with
prostatitis syndromes. Survey of results. Urology 1993; 41: 301-307.
11.
J.J.M.C.H. de la Rosette, M.C.M. Ruijgrok, J. Jeuken, H.F.M. Karthaus, F.M.J.
Debruyne. Personality variables involved in chronic prostatitis. Urology1993; 42:
654-662.
12.
J.J.M.C.H. de la Rosette, M.R. Hubregtse, J.M. Wiersma, F.M.J. Debruyne. The
value of urine cytology in the screening of patients with prostatitis syndromes. Acta
Cytologica. 1993; 37: 711-712.
13.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, H.E. Schaafsma, R. van Dijk. Workup
and management of incidentally found hypoechoic lesions of the testis. Urol Int
1993; 51: 23-27.
14.
J.J.M.C.H. de la Rosette. Diagnostiek en behandeling van patiënten met prostatitis
klachten: veranderde inzichten? Nederlands Tijdschrift voor Urologie 1993; 1: 7-10.
15.
J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, F.M.J. Debruyne. Clinical results with
microwave thermotherapy of benign prostatic hyperplasia. Eur Urol 1993; 23: 68-71.
16.
J.D.M. de Vries, J.J.M.C.H. de la Rosette, E.J.K.J.E.M van Grunsven.
Urethraplasty, using the preputial island flap technique: revisted. Eur Urol 1993; 24:
77-80.
17.
R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J.
Debruyne, H. Wijkstra. Automated volume measurement of the prostate with
AUDEX. J Endourol.1993; 7 (suppl. 1): S191.
1994:
18.
J.J.M.C.H. de la Rosette. Microwave treatment of BPH: still an option? Arch Esp
de Urol. 1994; 47(9): 889-894.
19.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, G. Alivizatos, F.M.J.A. Froeling,
F.M.J. Debruyne. Transurethral microwave thermotherapy (TUMT) in benign
prostatic hyperplasia: placebo versus TUMT. Urology 1994; 44: 58-63.
20.
F.M.J.A. Froeling, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Minimaal invasieve
urologie: nieuwe ontwikkelingen van behandelingen in de urologie. NTVG 1994;
138(35): 1756-1760.
21.
M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, F.A.G. Bloem. R.
Laduc, F.M.J. Debruyne. Transurethrale microgolf thermotherapie (TUMT) bij de
behandeling van benigne prostaat hyperplasie. NTVG 1994; 138(35): 1764-1770.
Curriculum Vitae
6
J. de la Rosette
22.
F.M.J.A. Froeling, M.J.G. Sorber, J.J.M.C.H. de la Rosette, J.D.M. de Vries. The
non-palpable testis and the changing role of laparoscopy. Urology 1994; 43(2): 222227.
23.
R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, H.E. Schaafsma, M.P. van
Iersel, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. The reliability of computer/
analysis of ultrasonographic prostate images: the influence of inconsistent
histopathology. Ultrasound in Medicine & Biology 1994; 20:871-876.
24.
A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, R.G. Aarnink, F.M.J.
Debruyne, H. Wijkstra. Analysis of ultrasonographic prostate images for the
detection of prostatic carcinoma: the Automated Urologic Diagnostic EXpert
system. Ultrasound in Med & Biol 1994; 20: 1-10.
25.
G.J. Jager, J.O. Barentsz, J.J.M.C.H. de la Rosette, G. Rosenbusch. Preliminary
results of endorectal surface coil magnetic resonance imaging for local staging of
prostatic cancer. Radiologe 1994; 34: 129-133.
26.
R.G. Aarnink, R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, F.M.J.
Debruyne, H. Wijkstra. A practical clinical method for contour determination in
ultrasonographic prostate images. Ultrasound in Medicine and Biology 1994; 20:
705-717.
27.
M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Retreatment rate
after surgical and non-surgical treatments. Prog Clin Biol Res 1994; 386: 597-613.
28.
J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, G. Alivizatos, F.M.J. Debruyne. Laser
ablation of the prostate: experience with an ultrasound guided technique and a
procedure under direct vision. Eur Urol 1994; 25(1), 19-24.
29.
J.J.M.C.H de la Rosette, A. Tubaro, K. Hofner, S.S. Carter. Transurethral
microwave thermotherapy: past, present and future. World J Urol 1994; 12(6): 352356.
30.
R.J.B. Giesen, A.L. Huynen, J.J.M.C.H de la Rosette, H.E. Schaafsma, M.P van
Iersel, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra.The reliability of computer
analysis of ultrasonographic prostate images: the influence of inconsistent
histopathology. Ultrasound Med Biol 1994; 20(9): 871-876.
1995:
31.
J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, M.P. van
Iersel, F.M.J. Debruyne, H. Wijkstra. Automated analysis and interpretation of
transrectal ultrasonography images in patients with prostatitis. Eur Urol 1995; 27: 4753.
32.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, F.M.J. Debruyne, P.L. Kersten, H.
Wijkstra. Reliability of uroflowmetry investigations: results of a portable
homeflowmetry study. Neurourology and urodynamics 1995; 14: 534-536.
Curriculum Vitae
7
J. de la Rosette
33.
J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, F.M.J.
Debruyne, H. Wijkstra. Computerized analysis of transrectal ultrasonography images
in the detection of prostate carcinoma. Br J Urol 1995; 75: 485-491.
34.
J.J.M.C.H. de la Rosette, E. Te Slaa, M.J.A.M. de Wildt, F.M.J. Debruyne.
Experience with the Ultraline and Urolase laser fibers: is there any difference? World
J Urol 1995; 13: 98-103.
35.
J.J.M.C.H. de la Rosette, A. Tubaro, A. Trucchi, S.St.C. Carter, K Hofner.
Changes in pressure-flow parameters in patients treated by TUMT (version 2.0). J
Urol 1995; 153: 1526-1536.
36.
M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette. Transurethral microwave
thermotherapy: an evolving technology in the treatment of benign prostatic
enlargement. Br J Urol 1995; 76: 531-538.
37.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, E.L. Koldewijn, F.M.J. Debruyne, H.
Wijkstra. Variability of pressure flow analysis parameters in repeated cystometry in
patients with benign prostatic hyperplasia. J Urol 1995; 153: 1520-1525.
38.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette. Is there a correlation between prostate
size and bladder-outlet obstruction. World J Urol 1995; 13: 9-13.
39.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, E.L. Koldewijn, F.M.J. Debruyne, H.
Wijkstra. Variability of pressure flow analysis in repeated cystometry in patients with
benign prostatic hyperplasia. J Urol 1995; 153:1520-1525.
40.
P.F.W.M. Rosier, M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J. Debruyne,
H. Wijkstra. Analysis of Maximum Detrusor Contraction Power in Relation to
bladder emptying in patients with lower urinary tract symptoms and benign prostatic
enlargement. J Urol 1995; 154: 2137-2142.
41.
M.P. van Iersel, W.P.J. Witjes, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof.
Prostate-specific antigen density: correlation with histological diagnosis of prostate
cancer, benign prostatic hyperplasia and prostatitis. Br J Urol 1995; 76: 47-53.
42.
R.G. Aarnink, R.J.B. Giesen, J.J.M.C.H. de la Rosette, A.L. Huynen, F.M.J.
Debruyne, H. Wijkstra. Planimetric volumetry of the prostate: how accurate is it?
Physiol Meas 1995; 6:141-150.
43.
Tubaro, S.St.C. Carter, J.J.M.C.H. de la Rosette, K Hofner, A. Trucchi, C. Ogden,
L. Miano, M. Valenti, U. Jonas, F.M.J Debruyne. The prediction of clinical outcome
from transurethral microwave thermotherapy by pressure-flow analysis: a european
multicenter study. J Urol 1995; 153:1526-1530.
44.
R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, H.E. Schaafsma, R.G.
Aarnink, F.M.J. Debruyne, H. Wijkstra. Ultranonic computer imaging of the
prostate, correlation between longitudinal and transverse texture description. Eur J
Ultrasound 1995; 2: 145-149.
Curriculum Vitae
8
J. de la Rosette
45.
J. Donovan, H. Kay, P. Abrams, J.J.M.C.H. de la Rosette, S Brookes, A.C. Kinn
and the ICS-BPH study Group. Measuring Quality of life in men with urinary
symptoms: using the SF-36.Neurourology and urodynamics 1995; 14:559-560.
46.
M. Devonec, S.St.C. Carter, A Tubaro, J.J.M.C.H. de la Rosette, K Hofner, P.
Perrin. Microwave therapy. Current Opinion 1995; 5: 3-9.
47.
R.J.B Giesen, A.L. Huynen, R.G. Aarnink, J.J.M.C.H. de la Rosette, C. van de
Kaa, G.O.N Oosterhof, F.M.J Debruyne, H. Wijkstra. Computer analysis of
transrectal ultrasound images of the prostate for the detection of carcinoma: a
prospective study in radical prostatectomy specimens. J Urol 1995; 154: 1397-1400.
48.
Debruyne, H. Wijkstra. Automated prostate volume determination with
ultrasonographic imaging. J Urol 1995; 153:1549-1554.
49.
M.J.A.M. de Wildt, A. Tubaro, K Hofner, S.St.C. Carter, J.J.M.C.H. de la Rosette,
M. Devonec. Responders and nonresponders to transurethral microwave
thermotherapy: a multicenter retrospective analysis. J Urol 1995; 54:1775-1778.
50.
E. te Slaa, A.F. van Ettergem, C.A. van „t Hof, F.M.J. Debruyne, J.J.M.C.H. de la
Rosette. Durability of laser fibers. World J Urol 1995; 13: 83-87.
51.
A.Cannon, M. de Wildt, P.H. Abrams, J.J.M.C.H. de la Rosette. Urodynamics and
laser prostatectomy. World J Urol 1995; 13:134-136.
52.
E. te Slaa, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Urinary tract infections following laser prostatectomy: is
there a need for antibiotic prophylaxis? Br J Urol 1995; 76: 604-610.
53.
E. te Slaa, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Urodynamic assessment in the laser treatment of benign
prostatic enlargement. Br J Urol 1995; 76: 604-610.
54.
P.F.W.M. Rosier, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de
la Rosette. Outcome of treatment of patients with lower urinary tract symptoms
that are categorized „moderately obstructed‟, according to the L-PURR classification
and „not-obstructed‟ according to urethral resistance factor. Neurourology and
urodynamics 1995; 14: 562-564.
55.
M.J.A.M. de Wildt, E. te Slaa, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Urodynamic results of laser treatment in patients with
benign prostatic hyperplasia. Can outlet obstruction be relieved? J. Urol 1995; 154:
174-180.
56.
P.F. Rosier, J.J.M.C.H de la Rosette, H. Wijkstra, P.E. Van Kerrebroeck, F.M.J.
Debruyne. Is detusor instability in elderly males related to the grade of obstruction?
Neurourol Urodyn 1995; 14(6): 625-633.
Curriculum Vitae
9
J. de la Rosette
57.
J.J.M.C.H. de la Rosette, J.M. Fitzpatrick. The laser in the management of benign
prostatic hyperplasia. World J Urol 1995; 13(2): 73.
1996:
58.
E. Te Slaa, M.J.A.M. de Wildt, F.M.J. Debruyne, R. De Graaf, J.J.M.C.H. de la
Rosette. Urinary tract infections following laser prostatectomy: is there a need for
antibiotic prophylaxis. Br.J.Uro 1996; 77: 228.
59.
M.J.A.M. de Wildt, M. Hubregtse, G. Ogden, S.S.C. Carter, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. A 12-months study of the placebo effect in transurethral
microwave thermotherapy. Br.J.Urol 1996; 77: 221.
60.
P.F.W.M. Rosier, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de
la Rosette. Evaluation of detrusor activity during micturition in patients with benign
prostatic enlargement with a clinical nomogram. J. Urol 1996; 156: 473-479.
61.
J.J.M.C.H. de la Rosette, W.P.J. Witjes, F.M.J. Debruyne, P.L. Kersten, H.
Wijkstra. Improved reliability of uroflowmetry investigations: results of a portable
home-based flowmetry study. Br.J.Urol. 1996; 78: 385-390.
62.
J.J.M.C.H. de la Rosette. Evaluatie van de mictie met behulp van uroflowmetry:
het gebruik van een portable homeflowmeter. Profundum 1996; 3: 24-27.
63.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, K. Hofner, S.St.C. Carter, F.M.J.
Debruyne, A. Tubaro. Pressure/flow study analysis in patients treated with High
Energy Thermotherapy (Prostasoft 2.5). J.Urol. 1996; 156: 1428-1433.
64.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, K Hofner, S.St.C. Carter, F.M.J.
Debruyne, A. Tubaro. High energy thermotherapy in the treatment of benign
prostatic hyperplasia. Results of the European BPH study group. J.Urol. 1996; 156:
97-102.
65.
R. Muschter, J.J.M.C.H. de la Rosette, H. Whitfield, J-P Pellerin, S. Madersbacher
and D. Gillatt. Initial Human Clinical Experience with Diode Laser Interstitial
Treatment of BPH. Urology 1996; 48: 223-228.
66.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra:
Reproducibility of transrectal ultrasound of the prostate concerning planimetric
volume determinations. Br. J. Urol. 1996; 78: 219-223.
67.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Formula
derived prostate volume determination. Eur Urol 1996; 29: 399-402.
68.
R.G. Aarnink, J.J.M.C.H. de la Rosette, A.L. Huynen, R.J.B. Giesen, F.M.J.
Debruyne, H. Wijkstra. Standardized assessment to enhance the diagnostic value of
prostate volume, Part I: morphometry in patients with lower urinary tract symptoms.
The Prostate 1996; 9(5): 317-326.
Curriculum Vitae
10
J. de la Rosette
69.
R.G. Aarnink, J.J.M.C.H. de la Rosette, A.L. Huynen, R.J.B. Giesen, F.M.J.
Debruyne, H. Wijkstra. Standardized assessment to enhance the diagnostic value of
prostate volume, Part II: correlation with PSA levels. The Prostate 1996; 29(5): 327333.
70.
E. te Slaa, J.J.M.C.H. de la Rosette. Lasers in the treatment of benign prostatic
obstruction: past, present and future. Eur. Urol. 1996; 30: 1-10.
71.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, H. Wijkstra, Ph.E.V.A. van
Kerrebroeck, F.M.J. Debruyne. Is detrusor instability in elderly males related to the
grade of obstruction. Neuro Urol Urodyn 1996 14: 625-635.
72.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, F.M.J. Debruyne,
H. Wijkstra. Comparison of passive urethral resistance relation and urethral
resistance factor in analysis of bladder outlet obstruction in patients with benign
prostatic enlargement. Neuro Urol Urodyn. 1996; 15: 1-15.
73.
K. Ezz El Din, J.J.M.C.H. de la Rosette. Transrectal ultrasound of the prostate.
Br.J.Urol. 1996; 78: 2-9.
74.
M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy
transurethral microwave thermotherapy: a thermoablative treatment for benign
prostatic obstruction. Urology 1996; 48: 416-423.
75.
G.J. Jager, J.O. Barentz, E.T.G. Ruijter, J.J.M.C.H. de la Rosette, G.O.N.
Oosterhof. Primary staging of prostate cancer. Eur.Radiol. 1996; 6: 129-133.
76.
C.F.P van Swol, E. te Slaa, R.M. Verdaasdonk, J.J.M.C.H. de la Rosette, T.A.
Boon. Variation in output power of laser prostatectomy fibers: a need for power
measurement. Urology 1996; 47: 672-678.
77.
G.J. Jager, E.T.G. Ruijter, C.A. van de Kaa, J.J.M.C.H. de la Rosette, G.O.N.
Oosterhof, J.R. Thornbury, J.O. Barentz. Local Staging of Prostate Cancer with
Endorectal MR imaging: Correlation with Histopathology. A.J.R. 1996; 66: 845-852.
78.
R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J.
Debruyne, H. Wijkstra. Construction and application of a hierarchical decision tree
for the classification of ultrasonographic prostate images. Medical & Biological
Engeneering & Computing 1996; 34:105-109.
79.
W.F.R.M. Koch., K. Ezz El Din, M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H.
de la Rosette. The outcome of renal ultrasound in the assessment of 556
consecutive patients with benign prostatic hyperplasia. J Urol 1996; 155: 186-189.
80.
M.P. van Iersel, C.M.G. Thomas, W.P.J. Witjes, R. de Graaf, J.J.M.C.H. de la
Rosette. F.M.J. Debruyne. Clinical implications of the rise and fall of PSA after laser
prostatectomy. Br.J.Urol. 1996; 78: 742-746.
Curriculum Vitae
11
J. de la Rosette
81.
P.F.W.M. Rosier, M.J.A.M. de Wildt, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de
la Rosette. Clinical diagnosis of bladder outlet obstruction in patients with benign
prostatic enlargement and lower urinary tract symptoms: development and
urodynamic validation of a clinical prostate score for the objective diagnosis of
bladder outlet obstruction. J. Urol. 1996; 155:1649-1654.
82.
K. Ezz El Din, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. The correlation between urodynamic and cystoscopic
findings in elderly men with voiding complaints. J Urol 1996; 155: 1018-1022.
83.
K. Ezz El Din, W.F.R.M. Koch, M.J.A.M. de Wildt, L.A.L.M. Kiemeney, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Reliability of the international prostate
symptom score (IPSS) in the assessment of patients with lower urinary tract
symptoms and/or benign prostatic enlargement. J Urol. 1996; 155: 1959-1964.
84.
A. Jardin, K.E. Andersson, C.C. Schulman, D. Graham, J.M. Buzelin, J.J.M.C.H. de
la Rosette, T.Christmas, C.R. Chapple. Consensus Meeting on New approaches in
the Pharmacotherapy of Benign Prostatic Hyperplasia (BPH). Eur Urol 1996;
29:374-384.
85.
J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, C. Chapple, J.J.M.C.H.
de la Rosette and A. Kondo. The ICS-„BPH‟Study: the psychometric validity and
reliability of the ICS male questionnare. Br.J.Urol. 1996; 77: 554-562.
86.
M.J.A.M. de Wildt, F.C.H. d‟Ancona, M. Hubregtse, S.St.C. Carter, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. 3 Years follow-up in patients treated with lowwer energy
thermotherapy (Prostasoft version 2.0). J. Urol. 1996; 156: 1959-1963.
87.
K. Ezz El Din, L.A.L.M. Kiemeney, M.J.A.M. de Wildt, P.F.W.M. Rosier, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. The correlation between uroflowmetry,
prostate volume, postvoid residue and lower urinary tract symptoms as measured by
the international prostate symptom score. Urology 1996; 48: 393-397.
88.
E. te Slaa, J.J. Mooibroek, Th.M. de Reijke, H.F.M. Karthaus, J-W. van Capelle, N.
Tjon Pian Gi, J.J.M.C.H. de la Rosette. Laser treatment of the prostate using the
urolase fiber: the dutch experience. J.Urol. 1996; 156: 420-425.
89.
K. Ezz El Din, L.A.L.M. Kiemeney, M.J.A.M. de Wildt, P.F.W.M. Rosier, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette.The correlation between bladder outlet
obstruction (BOO) and lower urinary tract symptoms (LUTS) as measured by the
international prostate symptom score (IPSS). J.Urol. 1996; 156: 1020-1025.
90.
K. Ezz El Din, W.F.R.M. Koch, M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H.
de la Rosette. The predictive value of microscopic haematuria in patients with
lower urinary tract symptoms and benign prostatic hyperplasia. Eur.Urol 1996; 30:
409-413.
Curriculum Vitae
12
J. de la Rosette
91.
W.P.J. Witjes, M.J.A.M. de Wildt, P.F.W.M. Rosier, C.T.M. Caris, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Variability of clinical and pressure-flow study variables
after 6 months of watchful waiting in patients with lower urinary tract symptoms and
benign prostatic enlargement. J. Urol.1996; 156: 1026-1034.
92.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra.
Computerised interpretation of ultrasonographic prostate images in the early
diagnosis of prostate cancer - the AUDEX system. Oncology in practice1996; 2/96:
11-13.
93.
Debruyne, H. Wijkstra. Automated prostate volume determination with
ultrasonographic imaging. J Urol 1996; 155: 1038.
94.
W.P.J. Witjes, P.F.W.M. Rosier, M.J.A.M. de Wildt, M.P. van Iersel, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of terazosin
therapy in patients with symptomatic benign prostatic hyperplasia. J Urol 1996; 155:
1317.
95.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Formula
derived prostate volume determination. Eur Urol 1996; 29(4): 399.
96.
G.J. Jager, J.O. Barentz, E.T. Ruijter, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof.
Primary staging of prostate cancer. Eur Radiol 1996; 6(2): 134-139.
99.
J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, C. Chapple, J.J.M.C.H.
de la Rosette, A. Kondo, ICS”BPH” Study group. The ICS -”BPH” study: The
psychometric validity and reliability of ICSmale questionnaire. Br.J.Urol 1996; 77:
554-562.
1997:
100.
F.C.H. d‟Ancona, E.A.E. Francisca, F.M.J. Debruyne, J.J.M.C.H. de la Rosette.
High energy transurethral microwave thermotherapy in the treatment of patients
with lower urinary tract symptoms. J Endo urol 1997; 11(4): 285-289.
101.
W.P.J. Witjes, J.J.M.C.H. de la Rosette, J.L. Donovan, T.J. Peters, P. Abrams,
H.E. Kay, K. Hofner, A.C. Kinn, S. Walter, ICS-”BPH” study group. The ICS”BPH” study: International differences in lower urinary tract symptoms and related
bother. J Urol 1997; 157: 1295-1300.
102.
J.J.M.C.H. de la Rosette, H.P. Beerlage, F.M.J. Debruyne. Role of Temporary
stents in alternative treatment of benign prostatic hyperplasia. J Endorurol 1997;
11(6): 467-472.
Curriculum Vitae
13
J. de la Rosette
103.
J.L. Donovan, H.E. Kay, T.J. Peters, P. Abrams, J. Coast, A. Matos-Ferreira, L.
Rentzhog, J.L.H.R. Bosch, J. Nordling, J.B. Gajewski, G. Barbalias, E. Schick, M.
Mendes Silva, I. Nissenkorn, J.J.M.C.H. de la Rosette. Using the ICSQol to
measure the impact of lower urinary tract symptoms on quality of life: evidence
from the ICS-BPH study. Br. J. Urol. 1997; 80: 712-721.
104.
T.J. Peters, J.L. Donovan, H.E. Kay, P. Abrams, J.J.M.C.H. de la Rosette, D.
Porru, J.W. Thuroff and the international continence society “BPH” study group.
The international continence society “benign Prostatic Hyperplasia” study: the
bothersomeness of urinary symptoms. J. Urol 1997; 157: 885-889.
105.
G. Jager, E. Ruijter, J.J.M.C.H. de la Rosette, C. Van de Kaa. Amyloidosis of the
Seminal Vesicles Simulating Tumor Invasion of Prostatic Carcinoma on Endorectal
MR Images. Eur Radiol 1997; 7(4): 552-454.
106.
G. Jager, E. Ruijter, C. van de Kaa, J.J.M.C.H. de la Rosette, G. Oosterhof, J.
Thornbury, J. Ruijs, J. Barentsz. Dynamic Turbo-FLASH Subtraction Technique for
Contrast-enhanced MR images of the Prostate: Correlation with Histopathology.
Genitourinary radiology 1997; 203: 645-652.
107.
A. Heerschap, G. Jager, M. van der Graaf, J. Barentsz, J.J.M.C.H. de la Rosette, G.
Oosterhof, E. Ruijter, J. Ruijs. In-vivo Proton MR Spectroscopy Reveals Altered
Metabolic Content in Malignant Prostate Tissue.Anticancer Res1997; 17: 1455-1460.
108.
P. Abrams, J. Donovan, J.J.M.C.H. de la Rosette, W. Schäfer and the ICS-‟BPH‟
study group. The international continence society “BPH” study: background, aims
and methodology. Neurourol and Urodynam 1997; 16(2): 79-92.
109.
E. te Slaa, E.A.E. Francisca, J.C.M. Hendriks, L.A.L.M. Kiemeney, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Quality of life assessment in patients following
laserprostatectomy. Br. J Urol 1997; 80: 211-216.
110.
J.J.M.C.H. de la Rosette, F.C.H. d‟Ancona, F.M.J. Debruyne. Current status of
thermotherapy treatment of the prostate. J Urol 1997; 157: 430-438.
111.
F.C.H. d‟Ancona, E.A.E. Francisca, W.P.J. Witjes, L. Welling, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. High energy thermotherapy (TUMT) versus transurethral
resection (TURP) in the treatment of benign prostatic hyperplasia (BPH): results of
a prospective randomized study with a 1-year follow-up. J Urol 1997; 158: 120-125.
112.
K. Ezz El Din, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Making the diagnosis
of benign prostatic hyperplasia (BPH): a critical review. Eur Urol 1997; 31: 257-262.
113.
R. Aarnink and J.J.M.C.H. de la Rosette. A preprocessing algorith for edge
detection with multiple scale of resolution. European Journal of Ultrasound 1997; 5:
113-126.
Curriculum Vitae
14
J. de la Rosette
114.
W.P.J. Witjes, P.F.W.M. Rosier, C.T.M. Caris, F.M.J. Debruyne, J.J.M.C.H. de la
Rosette. Urodynamic and clinical effects of terazosin therapy in symptomatic
patients with and without bladder outlet obstruction: a stratified analysis. Urology
1997; 49: 197-206.
115.
W.P.J. Witjes, R.G. Aarnink, K. Ezz-El-Din, H. Wijkstra, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. The correlation between prostate volume, transition
zone volume, transition zone index and clinical and urodynamic investigations in
patients with symptomatic benign prostatic hyperplasia. Br. J Urol 1997;
80: 84-90.
116.
E.A.E. Francisca, F.C.H. d‟Ancona, J.C.M. Hendriks, L.A.L.M. Kiemeney, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Quality of life assessment in patients treated
with lower energy thermotherapy (Prostasoft 2.0): results of a randomized TUMT
versus SHAM study. J Urol 1997; 158: 1839-1844.
117.
J.J.M.C.H. de la Rosette, R. Muschter, M.A. Lopez, D. Gillatt. Interstitial laser
coagulation (ILC) in the treatment of benign prostatic hyperplasia (BPH) using a
diode laser system with temperature feedback. Br.J.Urol 1997; 80: 433-438.
118.
Bierkens, A. Hendrikx, K. Ezz El Din, F.M.J. Debruyne, J.J.M.C.H. de la Rosette.
The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in
the prevention of urinary tract infections in patients with proven sterile urine prior
to treatment. Eur. Urol.1997; 31: 30-35.
119.
Y. Xue, F. Smedts, R. Umbas, T.W. Aalders, F.M.J. Debruyne, J.J.M.C.H. de la
Rosette, J.A. Schalken. Changes in keratin expression during the development of
benign prostatic hyperplasia (BPH). Eur Urol 1997; 32: 332-338.
120.
Yong Xue, Albert Verhofstad, Wil Lange, Frank Smedts, Frans M.J. Debruyne,
J.J.M.C.H. de la Rosette, Jack Schalken. Prostatic Neuroendocrine Cells Have a
Unique Keratin Expression Pattern and Do Not Express Bcl-2 --- cel kinetic
features of neuroendocrine cells in human prostate. Am J Pathol 1997; 151 (6):
1759-1765.
121.
Wim P.J. Witjes, H. Wijkstra, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette.
Quantitative assessment of uroflow: is there a circadian rhythm? Urology 1997; 50:
221-228.
122.
Wim P.J. Witjes, Andrew robertson, Peter F.W.M. Rosier, David E. Neal, Frans M.J.
Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of
noninvasive and minimally invasive treatments in elderly men with lower urinary
tract symptoms stratified according to the grade of obstruction. Urology 1997; 50:
55-61.
123.
R.G. Aarnink, J.J.M.C.H. de la Rosette, Wouter F.J. Feitz, Frans M.J. Debruyne,
H. Wijkstra. A preprocessing algorithm for edge detection with multiple scales of
resolution. European Journal of Ultrasound 1997; 5:113-126.
Curriculum Vitae
15
J. de la Rosette
1998:
124.
J.J.M.C.H. de la Rosette, M. Blute, F. Degrandchamps. Transurethral
thermotherapy using the Prostatron device. World J Urol 1998; 16(2):89-96.
125.
E.A.E. Francisca, M. Blute, J.J.M.C.H. de la Rosette. Quality of life in TUMT.
World J. Urol 1998; 16(2):148-153.
126.
H.P. Beerlage, Th. De Reijke, J.J.M.C.H. de la Rosette. Considerations regarding
prostate biopsies. Eur urol 1998; 34: 303-312.
127.
H.P. Beerlage, E.A.E. Francisca, F.C.H. d‟Ancona, F.M.J. Debruyne, J.J.M.C.H. de
la Rosette. Urolase versus ultraline fibers in laser prostatectomy; 3 year follow up of
a prospective randomized study. J Endodurol 1998; 12 (nr 6), 575-580.
128.
Frank C.H. d‟Ancona, Elmer A.E. Francisca, Wim P.J. Witjes, L. Welling, Frans M.J.
Debruyne, J.J.M.C.H. de la Rosette. Transurethral resection of the prostate
(TURP) versus high energy thermotherapy (HE-TUMT) of the prostate in patients
with benign prostatic hyperplasia (BPH): long-term results. Br.J Urol 1998; 81(2): 59264.
129.
F.C.H. d‟Ancona, E.A.E. Francisca, J.C.M. Hendriks, F.M.J. Debruyne, J.J.M.C.H.
de la Rosette. The predictive value of baseline variables in the treatment of benign
prostatic hyperplasia using high energy transurethral microwave thermotherapy. Br. J
Urol 1998; 82: 808-813.
130.
J.J.M.C.H. de la Rosette, W.P.J. Witjes, W. Schafer, P. Abrams, J.L. Donovan, T.J.
Peters, R.J. Millard, C Frimodt-Moller, P. Kalomiris and the ICS-BPH study group.
The relationship between lower urinary tract symptoms and bladder outlet
obstruction: Results from the ICS-BPH study. Neurourol 1998;17: 99-108.
131.
Y. Xue, J. Lie, M.A.H.E. Latijnhouwers, F. Smedts, R. Umbas, T.W. Aalders, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Expression of periglandular
tenascin-C and basement membrane laminin in normal prostate, benign prostatic
hyperplasia and prostate carcinoma. Br. J Urol 1998; 81: 844-851.
132.
Y. Xue, F. Smedts, A. Verhofstad, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A.
Schalken. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their
differential interrelationships: new perspectives. Prostate 1998;8: 62-73.
133.
G.B.J.M. Keijzers, E.A.E. Francisca, F.C.H. d‟Ancona, L.A.L.M. Kiemeney, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Long-term Results of Lower Energy TUMT
(Prostasoft 2.0). J Urol 1998; 159: 1966-1973.
134.
E. te Slaa, C.F.P. van Swol, T.A. Boon, R.M. Verdaasdonk, W.H. Doesburg, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. The influence of the decay of laser fibers
during laser prostatectomy on the clinical results. J Endourol 1998; 12(3): 291-295.
Curriculum Vitae
16
J. de la Rosette
135.
J. Van Drongelen, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la
Rosette. The impact of urometabolic evaluation on the prevention of urolithiasis: a
retrospective study. Urology 1998; 52(3), 384-391.
136.
R.G. Aarnink, H.P. Beerlage, J.J.M.C.H. de la Rosette, Frans M.J. Debruyne, H.
Wijkstra. Transrectal Ultrasound of the prostate: innovations and future
applications, J Urol. 1998 ,159: 1568-1579.
137.
Y.Xue, F. Smedts, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken.
Identification of intermediate cell types by keratin expression in the developing
human prostate. The prostate 1998; 34(4): 292-301.
138.
Y. Xue, W. Lange, F. Smedts, F. Debruyne, J.J.M.C.H. de la Rosette, J Schalken,
A. Verhofstad. A novel immunoenzymatic technique to demonstrate multiple
antigens in cells based on selective destaining of reaction products and its
application in characterizing the immunophenotype of neuroendocrine cells in the
human prostate. Applied immunihistochemistry 1998; 6(2): 69-76.
139.
A. Tubaro, J.J.M.C.H. de la Rosette, K. Hofner, A. Trucchi, and S.St.C. Carter.
Correlation amongst objective and subjective parameters of bladder outlet
obstruction in the clinical response to microwave thermotherapy. Urodinamica ,
1998; 8: 200-210.
140.
J.M. Reynard, Q Yang, J.L. Donovan, T.J. Peters, W. Schafer, J.J.M.C.H. de la
Rosette, N.F. Dabhoiwala, D Osawa, A. Tong Long Lim, P. Abrams. The ICS„BPH‟ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet
obstruction. Br. J Urol 1998; 82: 619-623.
141.
K. Hofner, A Tubaro, J.J.M.C.H. de la Rosette, S.St.C. Carter. Analysis of
Outcome After Thermotherapy Using Different Classifications of Bladder Outlet
Obstruction. Neurourol and Urodyn 1998; 17: 109-120.
142.
J. Donovan, S. Brookes, P. Abrams, J.J.M.C.H. de la Rosette. Are symptoms of
incontinence in men relieved by treatment for bladder outlet obstruction?: data from
the ICS-„BPH‟ study. Neurourol urodyn 1998; 17: 363-365.
143.
R.G. Aarnink, S.D. Pathak, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, Y. Kim,
H. Wijkstra. Edge detection in prostatic ultrasound images using integrated edge
maps. Ultrasonics 1998; 36: 635-642.
144.
A.F. Bierkens, A.J.M. Hendrikx, J.J.M.C.H. de la Rosette, G.N.M. Stultiens, H.P.
Beerlage, A.J. Arends, F.M.J. Debruyne. Treatment of mid-and lower ureteric calculi:
extracorporeal shock-wave lithotrypsie vs laser ureteroscopy. A comparison of costs,
morbidity and effectiveness. Br. J. Urol 1998; 81: 31-35.
145.
Y. Xue, F. Smedts, M.A.H.E. Lathouwers, E.T.H. Ruijter, T.W. Aalders, J.J.M.C.H.
de la Rosette, F.M.J. Debruyne, J.A. Schalken. Tenascin-C Expression in Prostatic
Intraepithelial Neoplasia (PIN): a marker of Progression? Anticancer Research 1998;
18: 2679-2684.
Curriculum Vitae
17
J. de la Rosette
146.
W.P. Witjes, J.J.M.C.H. de la Rosette, M. Zerbib, G.C. Vignoli, C. Geffriaud,
F.M.J. Debruyne, H. Wijkstra.Computerized artifact detection and correlation of
uroflow curves: towards a more consistent quantitative assessment of maximum
flow. Eur. Urol 1998; 33(1): 54-63.
148.
D. Floratos, J.J.M.C.H. de la Rosette. The value of urodynamics in laser
Prostatectomy. Eur Urol 1998; (37): 509-516.
1999:
149.
H.P. Beerlage, G.J.L.H. van Leenders, G.O.N. Oosterhof, J.A. Witjes, E.T. Ruijter,
C.A. van de Kaa, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High intensity
focused ultrasound (HIFU) followed after on to two weeks by radical retropubic
prostatecomy: results of a prospective study. Prostate 1999; 39(1): 41-46.
150.
F.C.H. D'Ancona, A.K. van der Bij, E.A. Francisca, H. Kho, F.M.J. Debruyne, L.A.
Kiemeney, J.J.M.C.H. de la Rosette. Results of high-energy transurethral
microwave thermotherapy in patients categorized according to the American Society
of Anesthesiologists operative risk classification. Urology 1999; 53(2): 322-328.
151.
F.C. d'Ancona, Y.H. Albers, L.A. Kiemeney, Y. Xue, F. Smedts, H.G. van der Poel,
F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Can histopathology predict treatment
outcome following high-energy transurethral microwave thermotherapy of the
prostate. Results of a biopsy study. Prostate 1999; 40(1): 28-36.
152.
H.P. Beerlage, S. Thuroff, F.M.J. Debruyne, C. Chaussy, J.J.M.C.H. de la Rosette.
Transrectal high-intensity focused ultrasound using the Ablatherm device in the
treatment of localized prostate carcinoma. Urology 1999; 54(2): 273-277.
153.
J.T. Bousema, M.J.G. Bussemakers, K.P. van Houwelingen, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette, L.A. Kiemeney. Polymorphisms in the vitamin D
receptor gene and androgen receptor gene and the risk of benign prostatic
hyperplasia. Eur Urol 1999; (37): 234-238.
154.
G.S. Sonke, L.A.L.M. Kiemeney, A.L.M. Verbeek, B.B.M. Kortmann, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Low Reproducibility of Maximum Urinary
Flow Rate Determined by Portable Flowmetry. Neurourol and Urodyn 1999; (18):
183-191.
155.
A. Martenson, J.J.M.C.H. de la Rosette. Interstitial Laser coagulation in the
treatment of BPH using a diode laser system: Results of an evolving technology.
Prostate Cancer and Prostatic Diseases 1999; (2): 148-154.
156.
E.A.E. Francisca, G.B.J.M. Keijzers, F.C.H. d‟Ancona, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Lower energy thermotherapy (TUMT 2.0) in the
treatment of BPH: Long term follow up results of a multicenter international study.
World J. Urol 1999; (17): 279-284.
157.
D.L. Floratos, J.J.M.C.H. de la Rosette. Lasers in Urology. Br.J.Urol 1999; (84):
204-211.
Curriculum Vitae
18
J. de la Rosette
158.
R.G. Aarnink, H.P. Beerlage, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H.
Wijkstra. Contrast Angiosonography: A technology to Improve Doppler Ultrasound
Examinations of the Prostate. Eur Urol 1999; (35): 9-20.
159.
J.L. Donovan, S.T. Brookes, J.J.M.C.H. de la Rosette, T.J. Peters, D. Porru, A.
Kondo, N. Dabhoiwala, R. Millard, R. Bosch, J. Nordling, A. Matos Ferreira, K.
Hofner, H. Mostafid, S. Walter, I. Nissenkorn, C. Frimodt Moller, M. Mendes Silva,
C. Chapple, P. Abrams. The responsiveness of the ICSmale questionnaire to
outcome: evidence from the ICS-„BPH‟ study. BJU International 1999; (83): 243248,.
160.
Yong Xue, Jeroen A.W.M. van der Laak, Mieke Latijnhouwer, Henk G. Van der
Poel, J.J.M.C.H. de la Rosette, Frans M.J. Debruyne, Jack A. Schalken. Transient
Tenascin Enhancement is an early event after Androgen Ablation in Rat Prostate.
Urol. 1999; Res 27,9-15.
161.
E.A.E. Francisca, F.C.H. d‟Ancona, E.J.H. Meuleman, F.M.J. Debruyne, J.J.M.C.H.
de la Rosette. Sexual function following high energy microwave thermotherapy:
results of a randomized controlled study comparing transurethral microwave
thermotherapy to transurethral prostatic resection. J Urol 1999; (161) 486-490.
162.
J.J.M.C.H. de la Rosette and A.R. Zlotta. Alternatives treatment in BPH: Future
perspectives. Eur Urol 1999; 35(2), 173-176.
163.
H.A. Bogers, J.P.M. Sedelaar, H.P. Beerlage, J.J.M.C.H. de la Rosette, F.M.J.
Debruyne, H. Wijkstra, R.G. Aarnink. Contrast-enhanced 3D Power Doppler
Angiography of the human prostate: correlation with biopsy outcome. Urology
1999; 54(1), 97-104.
164.
F.C.H. d‟Ancona, E.A.E. Francisca, J.C.M. Hendriks, F.M.J. Debruyne, J.J.M.C.H.
de la Rosette. How to select patients for high energy transurethral microwave
thermotherapy. Urology 1999; 53(1), 111-117.
165.
F.C.H. d‟Ancona, J.J.M.C.H. de la Rosette. Future perspectives of transurethral
microwave thermotherapy. Prostatic disease 1999; 3(2), 29-31.
166.
B.B.M. Kortmann, G.S. Sonke, F.C.H. d‟Ancona, D.L. Floratos, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. The tolerability of urodynamic studies and flexible
cystourethroscopy used in the assessment of men with lower urinary tract
symptoms. BJU International 1999; (84): 449-453.
167.
J.O. Barentsz, M.R.W. Engelbrecht, J.A.M. Witjes, J.J.M.C.H. de la Rosette, M.
van der Graaf. MR Imaging of the male Pelvis. Review article. Eur Radiol 1999 (9):
1722-1736.
2000:
168.
Y Xue, J. van der Laak, F. Smedts, C. Schoots, J. Schalken, A Verhofstadt,
J.J.M.C.H. de la Rosette. Neuroendocrine cells during human prostate
development: does neuroendocrine cells density remain constant during fetal as well
as postnatal life? Prostate 2000; 42(2):116-123.
Curriculum Vitae
19
J. de la Rosette
169.
G.J.L.H. van Leenders, H.P. Beerlage, E.Th. Ruijter, J.J.M.C.H. de la Rosette,
C.A. van de Kaa and D.J. Ruiter. Histopathologic changes associated with High
Intensity Focused Ultrasound (HIFU) therapy for localized adenocarcinoma of the
prostate. J. Clin Pathol 2000 (53): 391-394.
170.
J.J.M.C.H. de la Rosette, E.A.E. Francisca, B.B.M Kortmann, D.L. Floratos,
L.A.L.M. Kiemeney, F.M.J. Debruyne. Clinical efficacy of a new 30-minutes
algorithm for transurethral microwave thermotherapy (TUMT 3.5): initial results.
BJU International 2000 (86): 47-51.
171.
G.S. Sonke, T. Heskes, A.L. Verbeek, J.J.M.C.H. de la Rosette, L.A. Kiemeney.
Prediction of bladder outlet obstruction in men with lower urinary tract symptoms
using artificial neural networks.J Urol 2000; 163(1):300-305.
172.
J.P.M. Sedelaar, R.G. Aarnink, G.J.L.H van Leenders, H.P. Beerlage, F.M.J.
Debruyne, H. Wijkstra, J.J.M.C.H de la Rosette. The application of threedimensional contrast enhanced ultrasound to measure volume of affected tissue
after HIFU treatment for localized prostate cancer. Eur Urol, 2000 37(5): 559-568.
173.
B.B.M. Kortmann, G.S. Sonke, H. Wijkstra, J. Nordling, E. Kallestrup, N.R. Holm,
J.J.M.C.H. de la Rosette. Intra-and inter-investigator variation in the analysis of
pressure-flow studies in men with lower urinary tract symptoms. Neurourol &
Urodyn 2000 (19): 221-232.
174.
D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Long-term follow up of laser treatment for lower urinary
tract symptoms of bladder outlet obstruction. Urology 2000; 163(5): 1457-1460.
175.
D. Unal, J.P.M. Sedelaar, R.G. Aarnink, G.J.L.H. van Leenders, H. Wijkstra, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Three dimensional contrast enhanced power
Doppler ultrasound and conventional examination methods: value of diagnostic
predictors of prostate cancer. BJU International 2000 (86): 58-64.
176.
J.J.M.C.H. de la Rosette. What we do and don‟t know about benign prostatic
hyperplasia. Curr Opin Urol 10:1-2, 2000.
177.
J.J.M.C.H. de la Rosette, M.P. Laguna, G. Pace, B.B.M. Kortmann, O. Selvaggio,
F.M.J. Debruyne, F.P. Selvaggi. Efficacy and Safety of the New High Energy 30
minute transurethral Microwave Thermotherapy: Results of 1 Year follow up in a
multicenter study. Techniques in Urology 2000; 6(4):271-275..
178.
D.L. Floratos, G.J. Alivizatos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette.
Transurethral Microwave Thermotherapy in the Armamentarium of Therapeutic
Modalities for Benign Prostatic Hyperplasia. Techniques in Urology 2000; 6(4):256261.
179.
G.S. Sonke, B.B.M. Kortmann, A.L.M. Verbeek, L.A.L.M. Kiemeney, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Variability of Pressure Flow Studies in Men
with Lower Urinary Tract Symptoms. Neurourology and Urodynamics 2000 (19):
637-656.
Curriculum Vitae
20
J. de la Rosette
180.
J.L. Donovan, T.J. Peters, P. Abrams, S.T. Brookes, J.J.M.C.H. de la Rosette, W.
Schafer. Scoring the short form ICS male SF Questionnaire. J Urol 2000 (164):
1948-1955.
181.
M.R.W. Engelbrecht, J.O. Barentsz, G.J. Jager, M van der Graaf, A. Heerschap,
J.P.M. Sedelaar, R.G. Aarnink, J.J.M.C.H. de la Rosette. Prostate cancer staging
using imaging. BJU International 2000(86) suppl 1: 123-134.
182.
E.A.E. Franciscs, B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Tolerability of 3.5 versus 2.5 High Energy
Transurethral Microwave Thermotherapy. Eur Urol 2000 (38): 59-63.
183.
D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, B.B.M. Kortman,
F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave
thermotherapy for the treatment of patients in urinary retention. J Urol 2000 (163):
1457-1460.
184.
G.J. Jager, J.L. Severens, J.R. Thornbury, J.J.M.C.H. de la Rosette, S.H.J. Ruijs,
J.O. Barentsz. Prostate Cancer Staging: Should MR Imaging be used? A decision
analytic approach. Radiology 2000(215): 445-451.
185.
E.A.E. Francisca, F.C. d‟Ancona, J.C. Hendriks, L.A. Kiemeney, F.M. Debruyne,
J.J.M.C.H. de la Rosette. A randomized study comparing high-energy TUMT to
TURP: quality of life aspects. Eur Urol 2000; 38(5): 569-575.
186.
M. Bolmsjo, S. Schelin, L. Wagrell, T. Larson, J.J.M.C.H. de la Rosette, A.
Mattiasson. Cell-kill modelling of microwave thermotherapy for treatment of BPH. J
Endourol 2000; 14(8): 627-635.
187.
G.S. Sonke, D. Kolman, J.J.M.C.H. de la Rosette, L.H.C. Donkers, P. Boyle,
A.L.M. Kiemeney. Prevalentie van lagere urinewegsymtomen bij mannen en de
invloed op hun kwaliteit van leven: het Boxmeer-onderzoek. NTVG 2000 144(53):
2558-2563.
188.
D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Long-term follow-up of laser treatment for lower urinary
tract symptoms suggestive of bladder outlet obstruction. Urology 2000 56(4): 604609.
190.
D.L. Floratos, G.J. Alivizatos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. TUMT
in the armamentarium of therapeutic modalities for 'BPH'. Tech urol. 2000 6(4): 256261. review.
2001:
191.
J.P.M. Sedelaar, G.J.L.H. van Leenders, C.A.Hulsbergen-van de Kaa, H.G. van der
Poel, J.A.W.M. van der Laak, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la
Rosette. Microvessel Density: Correlation between Contrast Ultrasonography and
Histology of Prostate Cancer. Eur Urol 2001; (40) 285-293.
192.
C. Roehrborn, G. Bartsch, R. Kirby, J Andriole, P. Boyle, J. de la Rosette, P.
Perrin, E. Ramsey, J. Nordling, G.de Campos Freire, S. Arap. Guidelines for the
diagnosis and treatment of benign prostatic hyperplasia: a comparative international
overview. Urology 2001; (58): 642-650.
Curriculum Vitae
21
J. de la Rosette
193.
M.P. Laguna, J.J.M.C.H. de la Rosette. The endoscopic approach to the distal
ureter in nephroureterectomy for upper urinary tract tumor. J Urol 2001; (166-6):
2017-2022.
194.
D.L. Floratos, J.J.M.C.H. de la Rosette. Heat treatment of the prostate: where do
we stand in 2000? Current Opinion in Urology 2001; (11): 35-41.
195.
S.P.C. Souverein, R.M.C. Herings, J.J.M.C.H. de la Rosette, A.J. Man in „t Veld,
R.D. Farmer, H.G.M. Leufkens. Evaluating adverse cardiovascular effects of drug
treatment for Benign Prostatic Hyperplasia (BPH): methodological considerations.
Journal of Clinical Epidemiology 2001; (54): 518-524.
196.
D.L. Floratos, L.A.L.M. Kiemeney, C. Rossi, B.B.M. Kortmann, F.M.J. Debruyne,
J.J.M.C.H. de la Rosette. Long-term follow up of a randomized TUMT versus
TURP study. J Urol 2001 (165): 1533-1538.
197.
J.J.M.C.H. de la Rosette, R.G. Aarnink. New Developments in Ultrasonography
for the Detection of Prostate cancer. J Endourol 2001(15): 93-104.
198.
B.S. Wadie, E-H. E. Ibrahim, J.J.M.C.H. de la Rosette, M.A. Gomha, M.A.
Ghoneim. The relationship between IPSS and the objective parameters in the
diagnosis of BOO: Part I: when statistics fail. J Urol 2001; 165(1): 32-34.
199.
P. Minnee, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral Microwave
Thermotherapy in Benign Prostatic Hyperplasia. Current Opinion in Urology 2001.
200.
C. Rossi, B.B.M. Kortmann, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney, H.
Wijkstra, J.J.M.C.H. de la Rosette. Alpha-blockade improves symptoms suggestive
of bladder outlet obstruction (BOO) but fails to relieve BOO itself. J Urol 2001;
(165): 38-41.
201.
F. Yue, E. Smedts, Th. Ruijter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A.
Schalken. Branching activity in the Human Prostate: a closer look at the structure of
small glandular buds. Eur Urol 2001; (39-2): 222-231.
202.
J.P.M. Sedelaar, T.E.B. Goosen, H. Wijkstra, J.J.M.C.H. de la Rosette.
Reproducibility of contrast-enhanced transrectal ultrasound of the prostate.
Ultrasound in Med. & Biol 2001; (27): 595-602.
203.
J.P.M. Sedelaar, P.L.M. Vijverberg, T.M. de Reijke, J.J.M.C.H. de la Rosette,
P.J.M. Kil, J.G. Braeckman, A.J.M. Hendrikx. Transrectal Ultrasound in the
Diagnosis of Prostate Cancer: State of the Art and Perspectives. Eur Urol 2001; (403): 275-284.
204.
J.P.M. Sedelaar, J.G.H. van Roermund, G.L.J.H. van Leenders, C.A. Hulsbergen van
de Kaa, H. Wijkstra, J.J.M.C.H. de la Rosette. Three-dimensional grayscale
ultrasound: evaluation of prostate cancer compared with benign prostatic
hyperplasia. Urology 2001; (57): 914-920.
205.
D.L. Floratos, J.P.M. Sedelaar, B.B.M. Kortmann, R.G. Aarnink, H.Wijkstra, F.M.J.
Debruyne, J.J.M.C.H. de la Rosette. Intra-Prostatic vasculature studies: can they
predict the outcome of transurethral microwave thermotherapy for the management
of bladder outflow obstruction? Prostate 2001; 46(3): 200-206.
Curriculum Vitae
22
J. de la Rosette
206.
J.J.M.C.H. de la Rosette, G. Alivizatos, M.P. Laguna. A critical evaluation of
transurethral hot-water balloon thermoablation: true facts and fiction. Current
Urology Reports 2001;(2 ):302-305.
207.
J.J.M.C.H. de la Rosette. Editorial. Eur Urol 2001; 40(3): 264.
208.
J.J.M.C.H. de la Rosette, G.Alivizatos, S. Madersbacher, M. Perachino, D.
Thomas, F. Desgrandchamps, M. de Wildt. EAU Guidelines on Benign Prostatic
Hyperplasia (BPH). Eur Urol 2001; (40): 256-263.
209.
Y. Xue, G. Sonke, C. Schoots, J. Schalken, A. Verhofstad, J.J.M.C.H. de la
Rosette, F. Smedts. Proliferative activity and branching morphogenesis in the
human prostate: a closer look at pre- and postnatal prostate growth. The Prostate
2001; (49): 132-139.
210.
J.J.M.C.H. de la Rosette. Introduction. Eur Urol 2001; 40(1).
211.
A.L. Hoffmann, J.J.M.C.H. de la Rosette, H. Wijkstra. Intraprostatic temperature
monitoring during transurethral microwave thermotherapy: status and future
developments. J Endourol 2001; 14(8): 637-642.
212.
D.L. Floratos, J.J.M.C.H. de la Rosette. The future role of microwave therapy in
benign prostatic hyperplasia. Urol Integr Invest 2001; (6-3): 215-223.
2002:
213.
M.P. Laguna, L.A. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Baseline
prostatic specific antigen does not predict the outcome of high energy transurethral
microwave thermotherapy. J Urol 2002: 1727-1730.
214.
G.S. Sonke, C.Robertson, A.L.M. Verbeek, W.P.J Witjes, J.J.M.C.H. de la Rosette,
A method for estimating within-patient variability in maximum urinary flow rate
adjusted for voided volume. Urology 2002; (59-3): 368-372.
215.
J.J.M.C.H. de la Rosette, B.B.M. Kortman, C. Rossi, G.S. Sonke, D.L. Floratos,
L.A.L.M. Kiemeney. Long-term risk of retreatment in patients using alpha-blockers
for lower urinary tract symptoms. J Urol 2002; (167): 1734-1739.
216.
J. Eckersley, J.P.M. Sedelaar, M.J. Blomley, H. Wijkstra, N.M. DeSouza, D.O.
Cosgrove, J.J.M.C.H. de la Rosette. Quantitative microbubble enhanced
transrectal ultrasound as tool for monitoring hormonal treatment of prostate cancer.
Prostate june 2002 51(4): 256-267.
217.
J.J.M.C.H. de la Rosette, D.K.E. van der Schoot, F.M.J. Debruyne. Recent
developments in guidelines on benign prostatic hyperplasia. Current Opinion in
Urology 2002; (12): 3-6.
218.
J. de la Rosette F.Smedts, C. Schoots, H. Hoek, P. Laguna. Changing patterns of
keratin expression characterize functional maturation in developing human bladder.
J Urol 2002; 168(2): 709-717.
219.
W.P.J. Witjes, J.J.M.C.H. de la Rosette, A. van den Berg-Segers, D. Colongo, G.
Koch, A.R. Zlotta, A. Colau, M.J.A.M. de Wildt, H. Wijkstra. Computerised
assessment of maximum urinary flow: an efficient, consistent and valid approach.
Eur Urol 2002 41(2): 206-213.
Curriculum Vitae
23
J. de la Rosette
220.
B. Djavan, J.C. Nickel, J.J.M.C.H. de la Rosette, P.Abrams. The Urologist view of
BPH progression: Results of an international servey. Eur. Urol 2002; 41(5): 490-496.
221.
J.J.M.C.H. de la Rosette, C.C. Abbou, J. Rassweiler, M.P. Laguna, CC. Schulman.
Laparoscopic radical prostatectomy: a European virus with global potentials. Arch.
Esp. Urol. 2002; 55(6): 603-609.
222.
P.C. Soeverein, R.M.C. Herings, A.J. Man in „t Veld, J.J.M.C.H. de la Rosette,
R.D.T. Farmer, H.G.M. Leufkens. Study of the association between ischemic heart
disease and use of alpha-blockers and finasteride indicated for the treatment of
benign prostatic hyperplasia. Eur. Urol. 2002; 42: 254-261.
223.
J. Veltman, T. Goossen, M.P. Laguna, H. Wijkstra, J.J.M.C.H. de la Rosette. New
technical improvements for TRUS in diagnosis of prostate cancer. Eur Urol.
Supplements 1; 2002; 1(6): 8-14.
224.
J. Vanderkerken, J.J.M.C.H. de la Rosette, M.P. Laguna, F.M.J. Debruyne. How
and when to take prostate biopsies. Eur. Urol. Supplements 1; 2002; 1(6): 15-20.
225.
J.P.M. Sedelaar, G.J.L.H. van Leenders, T.E.B. Goossens, C.A. Hulsbergen-van der
Kaa, N.P. van Adrichem, H. Wijkstra, J.J.M.C.H. de la Rosette. The value of
contrast ultrasonography in the detection of significant prostate cancer: correlation
with radical prostatectomy specimens. Prostate 2002; 53: 246-253.
2003:
226.
P.C. Souverein, R.M.C. Herings, J.A. Erkens, J.J.M.C.H. de la Rosette, H.G.M.
Leufkes, H.G.M. Leufkens. Drug treatment of benign prostatic hyperplasia and
hospital admission for BPH-related surgery. Eur Urol. 2003; 43: 528-534.
227.
A.L. Hoffmann, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra.
Quantification of Prostate shrinkage after microwave thermotherapy: a comparison
of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur. Urol. 2003;
181-187.
228.
M. Emberton, G. Andriole, J. de la Rosette, B. Djavan, K. Hofner, V. Navarrete, J.
Nordling, C. Roehrborn, C. Schulman, P. Teillac, A. Tubaro, C. Nickel. BPH: A
progressive disease of the ageing male. Urology. 2003; 61: 267-273.
229.
S. Gravas, M.P. Laguna, J.J.M.C.H. de la Rosette. Thermotherapy and
thermoablation for BPH. Curr. Opnion Urol. 2003; 13: 45-49.
230.
J.J.M.C.H. de la Rosette, M.P. Laguna, S.Gravas, M.J.A.M. de Wildt. Transurethral
Microwave Thermotherapy: the 'gold standard' for minimal invasive therapies in
patients with Benign prostatic Hyperplasia (BPH). Jour. Endourol 2003; 4: 245- 251
231.
M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van
der Kaa., J.J.M.C.H. de la Rosette, R. Weissleder. Noninvasive detection of
clinically occult lymph-node metastases in prostate cancer. N Engl J Med.
2003;348(25):2491-9.
232.
S.Gravas, M.P. Laguna, P.J. van Hest, J.J.M.C.H. de la Rosette. Efficacy and safety
of intraprostatic temperature controlled microwave thermotherapy in patients with
benign prostatic hyperplasia: Results of a porspective, open label, single center study
with 1-year follow up. J. Endourol. 2003; 17: 425-430.
Curriculum Vitae
24
J. de la Rosette
233.
T.M. de Reijke, H.P.Beerlage, A.J. Hendrikx, J.J.M.C.H. de la Rosette, C.A.
Mc.Killop. Prostate cancer: the right treatment for the right patient. Amsterdam 17 18 Januari 2001. Prostate Cancer Prostatic Dis. 2003; 6(2): 193-197.
234.
B.W.Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette. Long-term results after
extrernal beam radiation therapy for T1-T2 localixes prostate cancer. Curr. Urol.
Rep. 2003; 4:240-247.
235.
D.L. Floratos, M.P. Laguna, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J. M.C.H. de
la Rosette. Transurethral Resection versus Microwave Thermotherapy of the
Prostate. A Cost-Consequences Analysis. BJU 2003; 92: 713-718.
236.
C.A. Mochtar, L.A.L.M. Kiemeney, M.M. van Riemsdijk, G.S. Barnet, M.P. Laguna,
F.M.J. Debruyne, J.J.M.C.H. de la Rosette. PSA as an estimator of prostate
volume in the management of patients with symptomatic BPH. Eur. Urol. 2003; 44:
65-700.
237.
B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de
la Rosette. Urodynamic Effects of Alpha-Adrenoceptor Blockers: A Review of
Clinical Trials. Urology 2003; 62:1-9.
238.
T.E.B. Goossen, J.J.M.C.H. de la Rosette, C.A. Hulsbergen-van de Kaa, H.
Wijkstra. The value of dynamic contrast enhanced power Doppler ultrasound
imaging in the localization of prostate cancer. Eur Urol 2003. 43(2):124-131.
239.
M.R. Engelbrecht, H.J. Huisman, R.J.R. Laheij, G.J. Jager, G.J.L.H. van Leenders,
C.A. Hulsbergen-van de Kaa, J.J.M.C.H. de la Rosette, J.G. Blickman, J.O.
Barentsz. Discrimination of prostate cancer from peripheral zone and central zone
gland tissue using dynamic contrast-enhanced MR imaging. Radiology. 2003.
229(1):248-54. Epub 2003 Aug 27.
240.
J.P.M. Sedelaar, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Progress in imaging of
the prostate gland. Curr Urol Rep. 2003. 4(1):1-2.
2004:
241.
M. Marberger., R. Harkaway, J.J.M.C.H. de la Rosette. Optimising the medical
management of BPH. Eur. Urol. 2004; 45: 411-419. review
242.
C. Huidobro, M. Bolmsjö, T. Larson, J.J.M.C.H. de la Rosette, L. Wagrell, S.
Schelin, T. Gorecki, A. Mattiasson. Evaluation of Prostalund coretherm microwave
theromotherapy with histo-pathology, MRI and temperature mapping. J.Urol. 2004;
171:672-678.
243.
T. Horn, B.B. Kortmann, N.R. , F. Smedts, J. Nordling, L.A. Kiemeney, J.J.M.C.H.
de la Rosette. Routine bladder biopties in men with bladder outlet obstruction?
Urol. 2004; 63(3):451-456.
244.
F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, A. Verhofstad, A. van
Leenders, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentz, Heerschap.
Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR
spectroscopic imaging of human prostate cancer. J. Magn Reson Imaging. 2004;
20(2):279-287.
Curriculum Vitae
25
J. de la Rosette
245.
C. Roehrborn, J. de la Rosette, G. Andriole. The utility of serial PSA measurements
for the diagnosis of prostate cancer is preserved in men treated with the dual 5αreductase inhibitor dutasteride.
246.
M.C. Michel, J.J.M.C.H. de la Rosette. Efficacy and safety of tamsulosin in the
treatment of urological diseases. Ashley Pub. Expert opinion Pharmacother. 2004;
5:1-10.
247.
N. Naderi, C.A. Mochtar, J.J.M.C.H. de la Rosette. Real life practice in the
management op BPH. Curr. Opin Urol 2004; 14: 41-44.
248.
P. Bhowmick, J.E. Coad, S Bhowmick, J.L. Pryor, T. Larson, J.J.M.C.H. de la
Rosette, J.C. Bischof. In vitro assessment of the efficacy of thermal therapy in
human benign prostatic hyperplasia. Int. J. Hyperthermia. 2004; 20(4): 421-439.
249.
F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, G.J. van Leenders, A.
Verhofstad, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentsz, A. Heerschap.
Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR
spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004
Aug;20(2):279-87.
250.
M.C. Michel, J.J.M.C.H. de la Rosette, M. Piro, M. Goepel.
Does concomitant stress incontinence alter the efficacy of tolterodine in
patients with overactive bladder? J Urol. 2004 Aug;172(2):601-4.
250.
S. Madersbacher, G. Alivizatos, J. Nordling, C.R. Sanz, M. Emberton, J.J.M.C.H.
de la Rosette. EAU 2004 guidelines on assessment, therapy and follow-up of men
with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH
guidelines). Eur Urol. 2004 Nov;46(5):547-54.
251.
H.Wijkstra, M.H. Wink, J.J.M.C.H. de la Rosette. Contrast specific imaging in the
detection and localization of prostate cancer.World J Urol. 2004; Oct 5.
252.
M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas.
Medical therapy of urinary incontinence.Internist (Berl). 2004; Dec 18.
253.
P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette,
M.Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha
blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004
May;45(5):620-6; discussion 626-7.
2005:
254.
A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Percutaneous
nephrolithotomy and its legacy. Eur. Urol. 2005; 47: 22-28
255.
M.P. Laguna, L.C. Schreuders, J.J. Rassweiler, C.C. Abbou, R. van Velthoven, G.
Janetschek, G. Breda, J.J.M.C.H. de la Rosette. Development of laparoscopic
surgery ans training facilities in Europe: Results of a survey of the ESUT. Eur. Urol.
2005; 47: 346-351.
256.
C.A. Mochtar, L.A..L.M. Kiemeney, M.P. Laguna, M.M. van Riemsdijk, G.S. Barnett,
F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Prognostic role of prostate-specific
antigen and prostate volume for the risk of invasive therapy in patients with BPH
initially managed with alpha1-blockers and watchful waiting. Urol. 2005; 65 (2):300305.
Curriculum Vitae
26
J. de la Rosette
257.
P.C. Souverein, M.M. van Riemsdijk, J.J.M.C.H. de la Rosette, P.C.E. Opdam,
H.G.M. Leufkes. Treatment pf BPH and occurrence of prostatic surgery and aute
urinary retention: A population-based cohort study in the Netherlands. Eur. Urol.
2005; 47:505-510.
258.
M.M. Barendrecht, R.P. Koopmans, J.J.M.C.H. de la Rosette, M.C. Michel.
Treatment of lower urinary tract symptoms suggestive of BPH : the cardiovascular
system. BJU 2005; 95(4): 19-28.
259.
B.W. Lagerveld, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette.
Holmium: YAG laser for treatment of strictures of vesicourethral anastomosis after
radial prostatectomy. J. Endourol. 2005; 4 (19): 497-501
260.
G. Kovacs, T. Loch, J. Hammer, R Potter, J.J.M.C.H. de la Rosette, H. Berterman.
GEC-ESTRO-EAU recommendations on high dose rate brachytherapy for localized
prostate cancer. J. Radiother Oncol. 2005; 74(2):137-148.
261.
M. van Dijk, T. Skrekas, J.J.M.C.H. de la Rosette. The associotion between lower
urinary tract symptoms ans sexual dysfunction: fact or fiction? Curr. Opin Urol 2005;
15:39-44.
262.
Martin C. Michel, J.J.M.C.H. de la Rosette. Role of muscarinic receptor
antagonists in urgency and nocturia. BJU 2005; 37-42 supp 1.
263.
M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of
urinary incontinence. Internist 2005 Jan; 46(1): 75-82.
264.
M.C. Michel, J.J.M.C.H. de la Rosette, M.Piro, T. Schneider. Comparison of
symptom severity and treatment response in patients with incontinent and continent
overactive bladder. European Urology 2005; 48: 110-115.
265.
P.C. Kauer, M.P. Laguna, G. Alivizatos, A.Jocye, R.Muschter, R.Swartz, D.Tolley,
J.J.M.C.H. de la Rosette. Present practice and treatment strategies in
endourological stone management: results of a survey of the European society of
uro-technology (ESUT). European Urology 2005; 48: 182-188.
266.
H. Azzouz, J.J.M.C.H. de la Rosette. Radical prostatectomy in high-risk prostate
cancer.Can J Urol. 2005 Jun; 12 Suppl 2: 33-7.
267.
M.P. Laguna, M. Brenninkmeijer, J.A. Belon, R. Marrero, H. Wijkstra, J.J.M.C.H.
de la Rosette, S. Isorna. Long-term functional and urodynamic results of 50 patients
receiving a modified sigmoid neobladder created with a short distal segment. J Urol.
2005 Sep; 174(3): 963-7.
268.
S. Gravas, M.P. Laguna, M. Ehrnebo, L. Wagrell, A. Mattiasson, J.J.M.C.H. de la
Rosette. Seeking evidence that cell kill guided thermotherapy gives results not
inferior to those of transurethral prostate resection: results of a pooled analysis of 3
studies of feedback transurethral microwave thermotherapy. J Urol. 2005 Sep;
174(3): 1002-6; discussion 1006.
269.
M.P. Laguna M.P., B. Lagerveld, L.P. Witte, I. Kümmerlin, H. Wijkstra, J.J.M.C.H.
de la Rosette. Laparoscopic assisted cryoablation of small renal masses. Actas Urol
Esp. 2005 Oct; 29(9): 860-8.
Curriculum Vitae
27
J. de la Rosette
270.
M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos
endourologicos en el aparato uirnario inferior. Arch Esp Urol 2005; 58(8): 703-706.
271.
endourologicos en el aparato urinario superior. Arch Esp Urol 2005; 58(8): 745-752.
272.
endourologicos en laparoscopia. Arch Esp Urol 2005; 58(8): 789-800.
273.
M.M. van Dijk , C.A. Mochtar, H. Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette.
Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary
tract symptoms due to bladder outlet obstruction. Urology 2005 Oct; 66(4): 845-9.
274.
T. Skrekas, M.P. Laguna, J.J.M.C.H. de la Rosette. Laparoscopic radical
prostatectomy: a European virus. Minimally Invasive Therapy 2005; 14:2: 98-103.
2006:
275.
C.A. Mochtar, L.A. Kiemeney, M.M. van Riemsdijk, M.P. Laguna, F.M. Debruyne,
J.J.M.C.H. de la Rosette. Post-void residual urine volume is not a good predictor
of the need for invasive therapy among patients with benign prostatic hyperplasia. J
Urol. 2006 Jan;175(1):213-6.
276.
M.P. Laguna, A. Arce-Alcazar, C.A. Mochtar, R.V. van Velthoven, A. Peltier,
J.J.M.C.H. de la Rosette. Construct validity of the chicken model in the simulation
of laparoscopic radical prostatectomy suture. J Endourol. 2006 Jan;20(1):69-73.
277.
M.M. van Dijk, C.A. Mochtar, H. Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette.
The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract
symptoms: experience in 108 patients. Eur Urol. 2006 Feb;49(2):353-9.
278.
M.M. van Dijk, J.J.M.C.H de la Rosette, and M.C. Michel. Effects of alpha 1adrenoceptor antagonists on male sexual function. Drugs 2006; 66 (3):287-301.
279.
M.P. Laguna, T.M. de Reijke, H. Wijkstra, J.J.M.C.H. de la Rosette. Training in
laparoscopic urology. Current Opinion in Urology 2006; 16 (2):65-70.
280.
C.A. Mochtar, W. Laan, K.P. Van Houwelingen, B. Franke, J.J.M.C.H. de la
Rosette, J.A. Schalken, L.A.L.M. Kiemeney. Polymorphisms in the alpha(1A)adrenoceptor gene do not modify the short- and long-term efficacy of alpha(1)adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Bju
International 2006; 97 (4):852-855.
281.
P. Laguna, F. Smedts, J. Nordling, T. Horn, K. Bouchelouche, A. Hopman,
J.J.M.C.H. de la Rosette. Keratin expression profiling of transitional epithelium in
the painful bladder syndrome/interstitial cystitis. American Journal of Clinical
Pathology 2006; 125 (1):105-110.
282.
J.J.M.C.H. de la Rosette, G. Alivizatos. Lasers for the Treatment of Bladder Outlet
Obstruction: Are They Challenging Conventional Treatment Modalities? Eur Urol.
2006; 50: 418-420.
283.
M. Oelke, K. Höfner, U. Jonas, D. Ubbink, J.J.M.C.H. de la Rosette, H.Wijkstra.
Ultrasound measurement of detrusor wall thickness in healthy adults.Neurourol
Urodyn. 2006; 25(4): 308-17.
Curriculum Vitae
28
J. de la Rosette
284.
M.C. Michel, J.J.M.C.H. de la Rosette. Alpha-Blocker Treatment of Urolithiasis.
Eur Urol. 2006; Mar 50: 213-214.
285.
J.J.M.C.H. de la Rosette, T. Skrekas, J.W. Segura. Handling and Prevention of
Complications in Stone Basketing.Eur Urol. 2006; 50: 991-999.
286.
A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Extracorporeal Shock Wave
Lithotripsy 25 Years Later: Complications and their Prevention. Eur Urol. 2006; 50:
981-990.
287.
C.A. Mochtar, L.A. Kiemeney, M.P. Laguna, F.M. Debruyne, J.J.M.C.H. de la
Rosette. PSA velocity in conservatively managed BPH: Can it predict the need for
BPH-related invasive therapy? Prostate. 2006 Sep 15; 66(13): 1407-12.
288.
M.H. Wink, H. Wijkstra, J.J.M.C.H. de la Rosette, C.A. Grimbergen. Ultrasound
imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied
Technol. 2006; 15(2):93-100.
289.
S. Gravas, P.Laguna, M. Melekos, J.J.M.C.H. de la Rosette. Current status of
minimally invasive treatment for benign prostatic obstruction. Acta Urológica 2006;
23 (1): 37-48.
290.
K. Kijvikai, M.P. Laguna, J.J.M.C.H. de la Rosette. Control of the large renal vein
in limited dissected space during laparoscopic nephrectomy: a simple and reliable
method. International Journal of Urology 2006; 13: 851-853.
291.
M.M.C. van den Heijkant, J.J.M.C.H. de la Rosette, T.M. de Reijke. Side effects of
hormonal therapy in prostate cancer. Polish Journal of Urology 2006; 59(1): 5-8.
292.
M.H. Wink, B.W. Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra.
Cryotherapy for renal-cell cancer: diagnosis, treatment and contrast enhanced
ultrasonography for follow-up. J Endourol. 2006; 20(7): 456-9.
293.
H. Azzouz, J.J.M.C.H. de la Rosette. HIFU: local treatment of prostate cancer.
EAU-EBU update series 4 2006: 62-70.
294.
J. Rassweiler, D. Teber, J.J.M.C.H. de la Rosette, M.P. Laguna, V. Pansodoro, T.
Frede. Laparoskopische beckenchirurgie. Wo stehen wir im jahr 2006? Urologe A
2006; Aug 10.
295.
J.J.M.C.H. de la Rosette. Extracorporeal shock wave lithotripsy and the “end of
stone age”. European Urology 2006; 50: 400-406.
296.
J.J.M.C.H. de la Rosette. Optimising assessment and treatment decisions for men
with BPH. European Urology 2006; 5: 710-715.
297.
K. Kijvikai, M. van Dijk, M.P. Laguna Pes, P. Lertsithichai, H. Wijkstra, J.J.M.C.H.
de la Rosette. Clinical utility of “blind placement” prostatic stent in patients with
benign prostatic obstruction: a prospective study. Urology 2006; 68(5):1025-30.
298.
T. Skrekas, C.A. Mochtar, B.W. Lagerveld, T.M. de Reijke, R.F. van Velthoven,
J.J.M.C.H. de la Rosette, M.P. Laguna. Mentor-initiated approach in laparoscopic
radical prostatectomy. J. Endourol 2006; 20(10): 831-5.
Curriculum Vitae
29
J. de la Rosette
299.
2007:
M.P. Laguna Pes, N. Wondergem, M.H. Wink, H. Wijkstra, J.J.M.C.H. de la
Rosette. Avances en el diagnóstico ecográfico del cancer de prostate. Arch. Esp.
Urol. 2006; 59(10): 965-976.
300.
H.C. Arentsen, J.J.M.C.H. de la Rosette, T.M. de Reijke, S. Langbein.
Fluorescence in situ hybridization: a multitarget approach in diagnosis and
management of urothelial cancer. Expert rev Mol Diagn. 2007 Jan; 7(1): 11-9.
301.
N. Wondergem, J.J.M.C.H. de la Rosette. HIFU and cryoablation – non or
minimal touch techniques for the treatment of prostate cancer. Is there a role for
contrast enhanced ultrasound? Minimally Invasive Therapy 2007; 16(1) : 22-30.
302.
J. Rassweiler, M. Schulze, C. Stock, D. Teber, J.J.M.C.H. de la Rosette. Bipolar
transurethral resection fo the prostate – technical modifications and early clinical
experience. Minimally Invasive Therapy 2007; 16(1): 11-21.
303.
M. Hatzinger, S. Langbein, J.J.M.C.H. de la Rosette, M. Sohn, P. Alken. Die
Nephropexie im Wandel der Zeit Aspekte einer historischen Operationstechnik.
Urologe A 2007; Jan 13.
304.
A. Breda, SV Stepanian, J. Liao , JS. Lam, G. Guazzoni, M. Stifelman, K. Perry, A.
Celia, G. Breda, P. Fornara, S. Jackman, J. Palo, M. Grasso, V. Pansadoro, V.
Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro,
J.J.M.C.H. De la Rosette, M.P. Laguna, and P.G. Schulam. Positive margins in
laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from USA
and Europe. Journal of Urology 2007;178(1):47-50.
305.
A. Skolarikos, G. Alivizatos, P. Laguna, J.J.M.C.H. de la Rosette. A review on
follow-up strategies for renal cell carcinoma after nephrectomy. European Urology
2007 jun;51(6):1490-501.
306.
M. Oelke, K. Höfner, U. Jonas, J.J.M.C.H. de la Rosette, D.T. Ubbink, H.
Wijkstra. Diagnostic accuracy of non-invasive tests to evaluate bladder outlet
obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine,
and prostate volume. Eur. Urol. 2007;52:827-835.
307.
J. Baard, Th.M. de Reijke, J.J.M.C.H. de la Rosette. The use of the Acucise
technique for ureteroplevic junction obstruction: a trade-off between efficacy and
invasiveness? Curr Urol Rep. 2007 Mar;8(2):134-9.
308.
M. Wink, M.P Laguna, B.W. Lagerveld, J.J.M.C.H. de la Rosette, H. Wijkstra.
Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal
tumours: a feasibility study. BJU int 2007 jun;99(6):1371-5.
309.
S. Gravas, P Laguna, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Durability of 30minute high-energy transurethral microwave therapy for treatment of beningn
prostatic hyperplasia: a study of 213 patients with and without urinary retention.
Urology 2007 may;69(5):854-8.
310.
B.W. Lagerveld, R.D. ter Wee, J.J.M.C.H. de la Rosette, J.A. Spaan, H.Wijkstra.
Vascular fluorescence casting and imaging cryomicrotomy for computerized threedimensional renal arterial reconstruction. BJU Int. 2007;100(2):387-91.
Curriculum Vitae
30
J. de la Rosette
311.
P. Tsakiris, J.J.M.C.H. de la Rosette. Imaging in genitourinary cancer from the
urologists‟ perspective. Cancer Imaging 2007 May 28;7:84-92.
312.
M.H. Wink, J.J.M.C.H. de la Rosette, M.P. Laguna, B.W. Lagerveld, H. Wijkstra.
Ultrasonography of renal masses using contrast pulse sequence imaging: a pilot
study. J Endourol. 2007;21(5):466-72.
313.
A. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao , I.S. Gill, J.R. Colombo, G. Guazzoni,
K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palo, M.
Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G.
Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna, and P.G.
Schulam. Use of haemostatic agnets and glues during laparoscopic partial
nephrectomy: a multi-institutional survey from the United States and Europe of
1347 cases. Eur. Urol. 2007;52(3): 798-803.
314.
M.H. Wink, J.J.M.C.H. de la Rosette, C.A. Grimbergen, H. Wijkstra. Transrectal
contrast enhanced ultrasound for diagnosis of prostate cancer. World J Urol. 2007;
25(4): 367-73.
315.
T.M. de Reijke, J.J.M.C.H. de la Rosette, C.N. Sternberg. Treatment approacges in
patients with hormone resistant prostate cancer. Polish Journal of Urology
2007;60(2):108-114.
316.
S.K. Williams, J.J.M.C.H. de la Rosette, J. Landman, F.X. Keeley jr. Cryoablation
of small renal tumors. EAU-EBU update series 2007;5:206-218.
317.
M.M. Barendrecht, P. Abrams, H. Schumacher, J.J.M.C.H. de la Rosette, M.C.
Michel. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms
by reducing bladder outlet resistance? Neurourol Urodyn 2007.
318.
K. Kijvikai, G.E. Haleblian, G.M. Preminger, J.J.M.C.H. de la Rosette. Shock
wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an
old discussion revisited. J Urol. 2007:178(4):1157-63.
319.
I.P. Kümmerlin, J. Borrego, M.H. Wink, M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de
la Rosette, M.P. Laguna. Nephron-sparing surgery and percutaneous biopsies in
renal-cell carcinoma: a global impression among endourologists. J Endourol.
2007;21(7):709-13.
320.
C.A. Mochtar, P.C. Kauer, M.P. Laguna, J.J.M.C.H. de la Rosette. Urinary leakage
after laparoscopic radical prostatectomy: a systematic review. J endourol.
2007;21(11):1371-80.
321.
S. Gravas, M.D. Melekos, M.P. Laguna, J.J.M.C.H. de la Rosette. Evaluation of
photoselective vaporization of the prostate. Aging Health 2007;3(6):723-730.
2008:
322.
J. van der Wijk jr., J. van der Wijk sr., T. Horn, J.R. Nyengaard, H. Wijkstra, J.
Nordling, F. Smedts, J.J.M.C.H. de la Rosette. Three-dimensional stereology as a
tool for evaluating bladder outlet obstruction. Scand J Urol Nephrol. 2008;42:40-46.
323.
P. Tsakiris, J.J.M.C.H. de la Rosette, M.C. Michel, M. Oelke. Pharmacologic
treatment of male stress urinary incontinence: systematic review of the literature and
levels of evidence. Eur. Urol. 2008;53(1):53-9.
Curriculum Vitae
31
J. de la Rosette
324.
G. Haleblian, K. Kijvikai, J.J.M.C.H. de la Rosette, G. Preminger. Ureteral
stenting and urinary stone management: a systematic review. J Urol 2008;179(2):42430.
325.
H. Wijkstra and J.J.M.C.H. de la Rosette. Editorial comment on: comparison of
contrast-enhanced color doppler imaging (CDI), computerized tomography (CT),
and magnetic resonance imaging (MRI) for the detection of crossing vessels in
patients with ureteropelvic junction obstruction (UPJO). Eur. Urol. 2008;53(6):12601.
326.
M. Emberton, M. Marberger, J.J.M.C.H. de la Rosette. Understanding patient and
physican perceptions of benign prostatic hyperplasia in Europe: the prostate research
on behaviour and education (PROBE) survey. Int J Clin Pract. 2008;62(1):18-26.
327.
M. Trompetter, F. Smedts, J. van der Wijk, C. Schoots, H.J. de Jong, A. Hopman,
J.J.M.C.H. de la Rosette. Keratin profiling in the developing human prostate. A
different approach to understanding epithelial lineage. Anticancer Research
2008;28:237-244.
328.
M.M. Barendrecht, P. Abrams, H. Schumacher, J.J.M.C.H. de la Rosette, M.C.
Michel. Do alpha(1)-adrenoceptor antagonists imrove lower urinary tract symptoms
by reducing bladder outlet resistance? Neurourol Urodyn. 2008;27(3):226-30.
329.
I. Kümmerlin, F. ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J.M.C.H. de la
Rosette, M.P. Laguna. Core biopsies of renal tumors: a study on diagnostic
accuracy, interobserver, and intraobserver variability. Eur. Urol. 2008;53(6):1219-27.
330.
L.P. Witte, C.R, Chapple, J.J.M.C.H. de la Rosette, M.C. Michel. Cholinergic
innervation and muscarinic receptors in the human prostate. Eur Urol.
2008:54(2):326-34.
331.
P. Tsakiris, S. Thüroff, J.J.M.C.H. de la Rosette, C. Chaussy. Transrectal highintensity focused ultrasound devices: a critical appraisal of the available evidence. J
endourol. 2008;22(2):221-229.
332.
P. Beemster, S. Phoa, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Followup of renal masses after cryosurgery using computed tomography; enhancement
patterns and cryolesion size. BJU int. 2008;101(10):1237-42.
333.
A. Skolarikos, J.J.M.C.H. de la Rosette. Prvention and treatment of complications
following percutaneous nephrolithotomy. Curr Opin Urol. 2008:18(2):229-34.
334.
M. Oelke, J. Baard, H. Wijkstra, J.J.M.C.H. de la Rosette, U. Jonas, K. Höfner.
Age and bladder outlet obstruction are independently associated with detrusor
overactivity in patients with benign prostates hyperplasia. Eur Urol. 2008:54(2):41926.
335.
J.J.M.C.H. de la Rosette. Facing the challenges of benign prostatic hyperplasia
management. Curr Opin Urol. 2008;18(1):9-10.
336.
J.J.M.C.H. de la Rosette, J. Rassweiler. Editorial: innovative approaches in
endoscopic surgery. J Endourol. 2008 Apr;22(4):743-4.
337.
S. Tabatabaei, O.M. Reich, J. de la Rosette, E.J. Collins, A. Bachmann, B.B. Choi,
G.H. Muir, F.G. Sancha, H.H. Woo. International multicenter experience of the
Curriculum Vitae
32
J. de la Rosette
greenlight HPS120W laser in patients with benign prostatic obstruction. J of Urol.
Suppl. S 2008; 179(4):627.
338.
H.H. Woo, O.M. Reich, J. de la Rosette, E.J. Collins, A. Bachmann, B. Choi, G.H.
Muir, F.G. Sancha, S. Tabatabaei. International multicenter experience of the
greenlight HPS120W laser in patients with benign prostatic obstruction, in urinary
retention, on anticoagulants and with large prostates. J of Urol. Suppl. S
2008;179(4):631.
339.
J.J.M.C.H. de la Rosette, M.P. Laguna, J.J. Rassweiler, P. Conort. Training in
Percutaneous Nephrolithotomy-A Critical Review. Eur Urol. 2008;54(5):994-1003.
340.
M.C. Michel, U. Wetterauer, M. Vogel, J.J. de la Rosette. Cardiovascular safety and
overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, postmarketing surveillance study. Drug Saf. 2008;31(6):505-14.
341.
S.F. Gomez, G. Muir, A. Bachmann, B. Choi, E. Collins, J. de la Rosette, O. Reich,
S. Tabatabei, H. Woo. Green light HPS laser prostatectomy: recommendations on
surgical technique. Eur. Urol. Supplements 2008;7(3):332.
342.
B. Choi, S. Tabatabaein, A. Bachmann, E. Collins, J. de la Rosette, F. Gomez
Sancha, G. Muir, O. Reich, H. Woo. GreenLight HPS 120-w laser for benign
prostatic hyperplasia: Comparative complications and technical recommendations.
Eur. Urol. Supplements. 2008;7(4):384-392.
343.
J.J.M.C.H. de la Rosette, E. Collins, A. Bachmann, B. Choi, G. Muir, O. Reich, F.
Gomez Sancha, S. Tabatabaei, H. Woo. Historical aspect of laser therapy for benign
prostatic hyperplasia. Eur. Urol. Supplements. 2008;7(4):363-369.
344.
G. Muir, F. Gomez Sancha, A. Bachmann, B. Choi, E. Collins, J. de la Rosette, O.
Reich, S. Tabatabaei, H. Woo. Techniques and training with GreenLight HPS120-W
laser therapy of the prostate: position paper. Eur. Urol. Supplements 2008;7(4):370377.
345.
H. Woo, O. Reich, A. Bachmann, B. Choi, E. Collins, J. de la Rosette, F. Gomez
Sancha, G. Muir, S. Tabatabaei. Outcome of GreenLight HPS 120-w laser therapy in
specific patient populations: those in retention, on antocoagulants, and with large
prostates (>=80 ml). Eur. Urol. Supplements 2008;7(4):378-383.
346.
P. Sountoulides, J.J.M.C.H. de la Rosette. Update on photoselcetive vaporization
of the prostate. Current Urology reports 2008;9:106-112.
347.
H.C. Arentsen, S. Langbein, J.J.M.C.H. de la Rosette, R.C.M. Pelger, S.D. Bos,
J.G. Fernandes, T.M. de Reijke. The nuclear matrix protein 22 (NMP22) bladderchek
test for the detection of bladder cancer. Polish Journal of Urology 2008;61:24-27.
348.
J.J.M.C.H. de la Rosette, S. Gravas, J.M. Fitzpatrick. Minimally Invasive treatment
of male lower urinary tract symptoms. Urologic Clinics of North America
2008:35;505-518.
349.
H. van Poppel, B. Tombal, J.J.M.C.H. de la Rosette, B.E. Persson, J.K. Jensen, T.
Kold Olesen. Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor
blocker-results from a 1-yr multicentre, randomized, phase 2 dosage-finding study in
the treatment of prostate cancer. Eur. Urol. 2008;54(4):805-15.
Curriculum Vitae
33
J. de la Rosette
350.
I. Kümmerlin, F.J. ten Kate, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna
Pes. Changes in the stage and surgical management of renal tumours during 19952005: an analysis of the Dutch national histopathology registry. BJU int.
2008;102(8):946-51.
351.
M. Wink, F. Frauscher, D. Cosgrove, J.Y. Chapelon, L. Palwein, H. Mitterberger, C.
Harvey, O. Rouvière, J.J.M.C.H. de la Rosette, H. Wijkstra. Contrast-enhanced
ultrasound and prostate cancer; a multicentre European research coordination
project. Eur Urol 2008;54(5):982-93.
352.
P.W.T. Beemster, B.W. Lagerveld, L.P.W. Witte, J.J.M.C.H. de la Rosette, M. P.
Laguna, H. Wijkstra. The Performance of 17-gauge cryoprobes in vitro. Technology
in cancer research & treatment 2008;7(4):321-328.
353.
J.Rioja, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna. Advances in diagnosis
and follow-up in kidney cancer. Curr. Opin. Urol. 2008;18(5):447-54.
354.
J.J.M.C.H. de la Rosette, P. Tsakiris, M.N. Ferrandino, A.M. Elsakka, J.Rioja,
G.M. Preminger. Beyond prone position in percutaneous nephrolithotomy: a
comprehensive review. Eur Urol 2008;54(6):1262-9.
355.
J.J.M.C.H. de la Rosette. Editorial Comment: Holmium Laser Enucleation of the
Prostate-Outcomes Independent of Prostate Size? J Urol 2008;180(6):2435.
356.
J.J.M.C.H. de la Rosette. Editorial comment on: Endoscopic combined intrarenal
surgery in Galdakao-modified supine Valdivia position : a new standard for
percutaneous nephrolithotomy. Eur. Urol 2008;54(6):1400-1.
357.
J.J.M.C.H. de la Rosette, J.J. Rassweiler. Bipolar TURP treatment for BPH
refractory to medication: the past, present, and future reference standard. J.
Endourol. 2008;22(9):2111-2.
358.
J.J. de la Rosette, J.R. Zuazu, P. Tsakiris, A.M. Elsakka, J.J. Zudaire, M.P. Laguna,
T.M. de Reijke. Prognostic factors and percutaneous nephrolithotomy morbidity: a
multivariate analysis of a contemporary series using the clavien classification. J Urol
2008;180(6):2489-93.
359.
A. Celia, G. Zeccolini, G. Guazzoni, V. Pansadoro, V. Disanto, F. Porpiglia, C.
Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomroo, P. Fornara, A. Breda,
P.G. Schulam, J.J. de la Rosette, M.P. Laguna, J. Palou, G. Breda. Laparoscopic
nephron sparing surgery: a multi-institutional European survey of 592 cases. Arch
Ital Urol Androl. 2008 Sep;80(3):85-91.
360.
J. Rioja Zuazu, V. Totziaris, M.P. Laguna Pes, T.M. de Reijke, J.J. de la Rosette.
Laser and bladder tumors. Arch Esp Urol 2008;61(9):994-1003.
2009:
361.
J.J.M.C.H. de la Rosette. Editorial Comment on: Mid-term results demonstrate
salvage High-Intensity Focused Ultrasound (HIFU) as an effective and acceptably
morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol.
2009;55(3):647-648.
362.
I.P. Kümmerlin, F. Smedts, F.J. Ten Kate, T. Horn, F. Algaba, I. Trias, H. Wijkstra,
J.J. de la Rosette, M.P. Laguna. Cytological Punctures in the Diagnosis of Renal
Tumours: A Study on Accuracy and Reproducibility. Eur Urol. 2009;55(1):187-198.
Curriculum Vitae
34
J. de la Rosette
363.
I.P. Kümmerlin, F.J. Ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J. de la
Rosette, M.P. Laguna. Diagnostic problems in the subtyping of renal tumors
encountered by five pathologists. Pathol Res Pract. 2009;205(1):27-34.
364.
C. Mamoulakis, M. Trompetter, J. de la Rosette. Bipolar transurethral resection of
the prostate: the golden standard reclaims it leading position. Curr Opin Urol
2009;19(1):26-32.
365.
J.J. de la Rosette. Tailoring treatment in benign prostatic hyperplasia management.
Curr Opin Urol 2009;19(1):1-2.
366.
L.P. Witte, W.M. Mulder, J.J. de la Rosette, M.C. Michel. Muscarinic receptor
antagonists for overactive bladder treatment: does one fit all? Curr Opin Urol
2009;19(1):13-9.
367.
M.C. Michel, R.F. Schäfers, J.J. de la Rosette. Drug interactions in urology. Urologe
A. 2009;48(3):264-9.
368.
M.P. Laguna, T.M. de Reijke, J.J. de la Rosette. How far will simulators be involved
into training. Current Urology Reports 2009;10:97-105.
369.
P. Tsakiris, P. Beemster, H. Wijkstra, J. de la Rosette, P. Laguna. In vivo factors
influencing the freezing cycle during cryoablation of small renal masses. J Endourol.
2009;23(3):545-9.
370.
T. Schneider, J.J. de la Rosette, M.C. Michel. Nocturia: a non-specific but
important symptom of urological disease. Int J Urol. 2009;16(3):249-56.
371.
P. Abrams, C. Chapple, S. Khoury, C. Roehrborn, J. de la Rosette. Evaluation and
treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):177987.
372.
M. Oelke, C. Mamoulakis, D.T. Ubbink, J.J. de la Rosette, H. Wijkstra. Manual
versus automatic bladder wall thickness measurements: a method comparison study.
World J Urol. 2009 December; 27(6): 747–753.
373.
E.C. Cauberg, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J. de la Rosette,
T.M. de Reijke. A new generation of optical diagnostics for bladder cancer:
technology, diagnostic accuracy and future applications. Eur. Urol. 2009;56(2): 28796.
374.
M.C. Michel, R.F. Schäfers, J.J. de la Rosette. Arzneimittelinteraktionen in der
urologie. Urologe 2009;48:264-269.
375.
E. Ramos-Barcelo, J. Rioja, P. Laguna Pes, J.J. de la Rosette, T. de Reijke. Is age a
prognostic factor for treatment outocme in renal cell cancer-a comprehensive
review. Crit Rev Oncol Hematol 2009;72(1):83-9.
376.
V. Tzortzis, S. Gravas, M.M. Melekos, J.J. de la Rosette. Intraurethral lubricants: a
critical literature review and recommendations. J endourol 2009;23(5):821-6.
377.
V. Tzortzis, C. Mamoulakis, J. Rioja, S. Gravas, M.C. Michel, J.J. de la Rosette.
Medical Expulsive Therapy for distal ureteral stones. Drugs 2009;69(6):677-692.
Curriculum Vitae
35
J. de la Rosette
378.
S. Gravas, C. Mamoulakis, J. Rioja, V. Tzortzis, T. de Reijke, H. Wijkstra, J.J. de la
Rosette. Advances in ultrasound technology in oncologic urology. Urol Clin N Am
2009;36:133-145.
379.
M.P. Laguna, P. Beemster, V.Kumar, S. Wyler, C. Anderson, F.X. Keeley, A.
Bachmann, J. Rioja, C. Mamoulakis, M. Marberger, J.J. de la Rosette. Perioperative
morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a
European multicentre experience. Eur. Urol. 2009;56(2):355-61.
380.
P.W. Beemster, I. Trias, F.J.W. ten Kate, F. Algaba, H. Wijkstra, J.J. de la Rosette,
M.P. Laguna Pes. The diagnostic yield of immediate postcryoablation biopsies of
small renal masses. J of Endourol 2009;23(7):1203-7.
381.
F. Wezel, C. Mamoulakis, J. Rioja, M.S. Michel, J. de la Rosette, P. Alken. Two
contemporary series of percutaneous tract dilatation for percutaneous
nephrolithotomy. J Endourol 2009;23(10):1655-61.
382.
E.C. Cauberg, J.J. de la Rosette, T.M. de Reijke. How to improve the effectiveness
of transurethral resection in nonmuscle invasive bladder cancer? Curr Opin Urol
2009;19(5):504-510.
383.
M.P. Laguna, I. Kümmerlin, J. Rioja, J.J. de la Rosette. Biopsy of a renal mass:
where are we now? Curr Opin Urol 2009;19(5):504-10.
384.
P. Tsakiris, P. Beemster, H. Wijkstra, J. de la Rosette, P. Laguna. In vivo factors
influencing the freezing cycle during cryoablation of small renal masses.J Endourol.
2009 Mar;23(3):545-9.
385.
Meissner A., C. Mamoulakis, J.J. de la Rosette, M.P. Laguna Pes. Clinical update on
testicular microlithiasis. Curr Opin Urol. 2009 Nov;19(6):615-8.
386.
M.M. van Dijk, H. Wijkstra, F.M. Debruyne FM, J.J. de la Rosette, M.C. Michel.
The role of nocturia in the quality of life of men with lower urinary tract symptoms.
BJU Int. 2009;105:1141-1146.
387.
H. Wijkstra, J.J.M.C.H. de la Rosette. Motion Corrected Cadence CPS Ultrasound
for Quantifying Response to Vasoactive Drugs in a Rat Kidney Model Editorial
Comment. Urology 2009;74(3): 681-682.
388.
J.J. de la Rosette, M.H. Wink, C. Mamoulakis, N. Wondergem, F.J. ten Kate, K.
Zwinderman, T.M. de Reijke, H. Wijkstra. Optimizing prostate cancer detection: 8
versus 12-core biopsy protocol. J Urol. 2009 Oct;182(4):1329-36.
389.
C. Mamoulakis, D.T. Ubbink, J.J. de la Rosette. Bipolar versus Monopolar
Transurethral Resection of the Prostate: A Systematic Review and Meta-analysis of
Randomized Controlled Trials. Eur Urol. 2009;56(5):798-809.
390.
J. de la Rosette. A platform for global endourological research. J Endourol. 2009
Oct;23(10):1551-3.
391.
J.J.M.C.H. de La Rosette, V. Mouraviev, T.J. Polascik. Focal Targeted Therapy
Will Be a Future Treatment Modality for Early Stage Prostate Cancer. Eur Urol
Suppl. 2009; 8(5): 424-432.
Curriculum Vitae
36
J. de la Rosette
392.
M.C. Martin, J.J.M.C.H. de la Rosette. Medical Treatment of Lower Urinary Tract
Symptoms Suggestive of Benign Prostatic Hyperplasia. Eur Urol Suppl 2009;
8(6):496-503.
393.
V. Tzortzis, S. Gravas, J.J.M.C.H. de La Rosette. Minimally Invasive Surgical
Treatments for Benign Prostatic Hyperplasia. Eur Urol Suppl 2009; 8(6): 513-522.
394.
M.M. van Dijk, M.A. van Dijk, H.Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette.
The effect of temporary prostatic stent on sexual functioning. Central Eur J of Urol
2009;62(2):243-248.
395.
P. Sountoulides, M.P. Laguna, J.J.M.C.H. de la Rosette. Complications follwing
augmentation cystoplasty; prevention and management. Central Eur J of Urol
2009;62(2):216-221.
396.
H. Sadri-Ardekani, S.C. Mizrak, S.K. van Daalen, C.M. Korver, H.L. RoepersGajadien, M. Koruji, S. Hovingh, T.M. de Reijke, J.J. de la Rosette, F. van der
Veen, D.G. de Rooij, S. Repping, A.M. van Pelt. Propagation of Human
Spermatogonial Stem Cells In Vitro. JAMA. 2009 Nov 18;302(19):2127-2134.
397.
L.P.W. Witte, U.Peschers, M. Vogel, J.J.M.C.H. de la Rosette, M.C. Michel. Does
the number of previous vaginal deliveries affect overactive bladder symptoms and
their response to treatment. LUTS 2009;1:82-87.
398.
J.J.M.C.H. de La Rosette. Editorial comment. J Endourol 2009;23(12):1949-50.
399.
J.J.M.C.H. de La Rosette. Editorial comment Urology 2009;74(6)1357.
2010:
400.
P. Sountoulides, M.M. van Dijk, H. Wijkstra, J.J. de la Rosette, M.C. Michel. Role
of voiding and storage symptoms for the quality of life before and after treatment in
men with voiding dysfunction. World J Urol. 2010 Feb;28(1):3-8.
401.
E.C. Cauberg, M.A. Salomons, I.P. Kümmerlin, T.M. de Reijke, A.H. Zwinderman,
J.J. de la Rosette, F.J. Kate, M.P. Laguna Pes. Trends in epidemiology and
treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis
of PALGA, the Dutch national histopathology registry. BJU Int. 2010
Apr;105(7):922-7.
402.
J. de la Rosette, S. Gravas. Global URS study: a prospective intenational
observational study on indications and perioperative outcomes. J of Endourol
2010;24(1):1-3.
403.
J. de la Rosette, S. Gravas. Guidelines for CROES publications. J of Endourol
2010;24(2):167-169.
404.
R. Heuer, I.S. Gill, G. Guazzoni, Z. Kirkali, M. Marberger, J.P. Richie, J.J. de la
Rosette. A Critical Analysis of the Actual Role of Minimally Invasive Surgery and
Active Surveillance for Kidney Cancer. Eur Urol. 2010 Feb;57(2):223-32
405.
S.C. Mizrak, J.V. Chikhovskaya, H. Sadri-Ardekani, S. van Daalen, C.M. Korver, S.E.
Hovingh, H.L. Roepers-Gajadien, A. Raya, K. Fluiter, T.M. de Reijke, J.J. de la
Rosette, A.C. Knegt, J.C. Belmonte, F. van der Veen, D.G. de Rooij, S. Repping,
A.M. van Pelt. Embryonic stem cell-like cells derived from adult human testis. Hum
Reprod. 2010;25(1):158-67.
Curriculum Vitae
37
J. de la Rosette
406.
G. Franco-Salinas, J.J. de la Rosette, M.C. Michel. Pharmacokinetics and
pharmacodynamics of tamsulosin in its modified-release and oral controlled
absorption system formulations. Clin Pharmacokinet. 2010 Mar 1;49(3):177-88.
407.
J. de la Rosette, S. Gravas. Quality and transparency in CROES research projects. J
of Endourol 2010;24(3):317.319.
408.
J. Rioja Zuazu, M. Hruza, J.J. Rassweiler, J.J. de la Rosette. The Clavien
classification system to optimize the documentation of PCNL morbidity. Archivio
Italinano di Urologia e Andrologia 2010;82(1):20-2.
409.
B.W. Lagerveld, P. van Horssen, M.P. Pes, J.P. van den Wijngaard, G.J. Streekstra,
J.J. de la Rosette, H. Wijkstra, J.A. Spaan. Immediate Effect of Kidney
Cryoablation on Renal Arterial Structure in a Porcine Model Studied by Imaging
Cryomicrotome. J Urol. 2010 Mar;183(3):1221-1226.
410.
J. de la Rosette, S. Gravas. Data transfer agreement form for CROES research
projects. J of Endourol 2010;24(4):501-504.
411.
E.C. Cauberg, S. Kloen, M. Visser, J.J. de la Rosette, M. Babjuk, V. Soukup, M.
Pesl, J. Duskova, T.M. de Reijke TM. Narrow Band Imaging cystoscopy improves
the detection of non-muscle-invasive bladder cancer. Urology. 2010;76(3):658-63.
412.
S. Eggener, G. Salomon, P.T. Scardino, J. de la Rosette, T.J. Polascik , S. Brewster
Focal therapy for prostate cancer: possibilities and limitations. Eur Urol. 2010
Jul;58(1):57-64.
413.
J. de la Rosette, S. Gravas. A multi-center, randomized international study to
compare the impact of narrow band imaging versus white light cystoscopy in the
recurrence of bladder cancer. J Endourol. 2010 May;24(5):660-1.
414.
P.W. Beemster, H. Wijkstra, J.J. de la Rosette, A.H. Zwinderman , M.P. Pes.
Quality of life and perceived pain after laparoscopic-assisted renal cryoablation. J
Endourol. 2010 May;24(5):713-9.
415.
C. Mamoulakis, J.J. de la Rosette, D.T. Ubbink. Re: Burke et al.: systematic review
and meta-analysis of transurethral resection of the prostate versus minimally invasive
procedures for the treatment of benign prostatic obstruction (Urology 2010;75:
1015-1022). Urology. 2010 May;75(5):1235-6.
416.
J. de la Rosette, I. Gill, T. Polascik. Focal therapy for prostate and renal cancer--are
we ready for it? J Endourol. 2010 May;24(5):663.
417.
J. de la Rosette, S. Gravas. Greenlight laser for benign prostatic hyperplasia study: a
prospective international observational study on indications and perioperative
outcomes. J of Endourol 2010;24(6):882-883.
418.
J. de la Rosette, H. Ahmed, J. Barentsz, T.B. Johansen, M. Brausi, M. Emberton, F.
Frauscher, D. Greene, M. Harisinghani, K. Haustermans, A. Heidenreich, G.
Kovacs, M. Mason, R. Montironi, V. Mouraviev, T. de Reijke, S. Taneja, S. Thuroff ,
B. Tombal, J. Trachtenberg, H. Wijkstra, T. Polascik. Focal therapy in prostate
cancer-report from a consensus panel. J Endourol. 2010 May;24(5):775-80.
Curriculum Vitae
38
J. de la Rosette
419.
A. Skolarikos, M.P. Laguna, G. Alivizatos, A.R. Kural, J.J. de la Rosette. The role
for active monitoring in urinary stones: a systematic review. J Endourol. 2010
Jun;24(6):923-30.
420.
J. de la Rosette, S. Gravas. Greenlight laser for benign prostatic hyperplasia study:
a prospective international observational study on indications and perioperative
outcomes. J Endourol. 2010 Jun;24(6):882-3.
421.
J.J. de la Rosette. Editorial comment. Urology. 2010 Jun;75(6):1458.
422.
M. Hruza, J.R. Zuazu, A.S. Goezen, J.J. de la Rosette, J.J. Rassweiler. Laparoscopic
and open stone surgery. Arch Ital Urol Androl. 2010 Mar;82(1):64-71.
423.
D.E. Zilberman, M.E. Lipkin, J.J. de la Rosette, M.N. Ferrandino, C. Mamoulakis,
M.P. Laguna, G.M. Preminger. Tubeless percutaneous nephrolithotomy--the new
standard of care? J Urol. 2010 Oct;184(4):1261-6.
424.
R. Autorino, G.P. Haber, R.J. Stein, A. Rane, M. De Sio, M.A. White, B. Yang, J.J.
de la Rosette, J.H. Kaouk, M.P. Laguna. Laparoscopic training in urology: critical
analysis of current evidence. J Endourol. 2010 Sep;24(9):1377-90.
425.
J. de la Rosette, S. Gravas. News from the publication office of CROES. J of
Endourol 2010;24(8):1203-1205
426.
I.P. Kümmerlin, F.J. ten Kate, H. Wijkstra, A. Zwinderman, J.J. de la Rosette, M.P.
Laguna. A decade of surgically removed small renal masses in the Netherlands:
characteristics and trends in type of surgery and pathologic reporting. J Endourol.
2010 Oct;24(10):1675-9.
427.
J. de la Rosette, S. Gravas. Progress report on CROES studies. J of Endourol
2010;24(9):1373-1376.
428.
J. de la Rosette, S. Gravas. News from CROES: time for acknowlegdment. J of
Endourol 2010;24(8):1552-1555.
429.
J. de la Rosette, S. Gravas. News from CROES: WCE 2010 and beyond. J
Endourol 2010;24(11):1704-4.
430.
E.C. Cauberg, D.M. de Bruin, D.J. Faber, T.M. de Reijke, M. Viseer, J. de la
Rosette, T.G. van Leeuwen. Quantitave measurement of attenuation coefficients of
bladder biopsies using optical coherence tomography for grading urothelial
carcinoma of the bladder. J Biomed Opt. 2010:15(6):066013-6.
431.
E.C.C. Cauberg, J.J. de la Rosette, T.M. de Reijke. Hematurie in de huisartspraktijk:
een beknopt overzicht. Modern Medicine 2010;34(2):81-84.
432.
J. de la Rosette, S. Gravas.Paul J. van Cangh: Food for thought. J of Endourol
2010;24(12):1895-1897.
2011:
433.
K. Kijvikai, J.J. de la Rosette. Assessment of stone composition in the management
of urinary stones. Nat Rev Urol. 2011;8(2):81-5.
Curriculum Vitae
39
J. de la Rosette
434.
E.C.C. Cauberg, C. Mamoulakis, J.J.M.C.H. de la Rosette, T.M. de Reijke. Narrow
band imaging-assisted transurethral resection for non-muscle invasive bladder cancer
significantly reduces residual tumour rate. World J Urol 2011; 29(4):503-9.
435.
J. de la Rosette, R. Davis III, D. Frankel. T. Kold Olesen. Efficacy and safety of
androgen deprivation therapy after switching from monthly leuprolide to monthly
degarelix in patients with prostate cancer. Int J Clin Pract 2011;65(5):559-66.
436.
M.C. Michel, M. Oelke, M. Vogel, J.J. de la Rosette. Which single-item measures of
overactive bladder symptom treatment correlate best with patient satisfaction?
Neurourology and urodynamics 2011;30(4):510-4.
437.
S. van Rees Vellinga, J. de la Rosette. The CROES data management system: a
glimpse behind the scenes. J Endourol 2011;25(1):1-5.
438.
K. Barwari, D.M. de Bruin, E.C. Cauberg, D.J. Faber, T.G. van Leeuwen, H.
Wijkstra, J. de la Rosette, M.P. Laguna. Advanced diagnostics in renal mass using
optical coherence tomography: a preliminary report 2011;25(2):311-5.
439.
J. de la Rosette, D. Assimos, M. Desai, J. Gutierrez, J. Lingeman, R. Scarpa, A.
Tefekli. The Clinical Research Office of the Endourological Society percutaneous
nephrolithotomy global study: indications, complications and outcomes in 5803
patients. J Endourol 2011;25(1):11-7.
440.
P.W. Beemster, K. Barwari, C. Mamoulakis, H. Wijkstra, J.J. De La Rosette, M.P.
Laguna. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: midterm oncological and functional results. BJU Int. 2011;108(4):577-82.
441.
J. Rioja, C. Mamoulakis, H. Sodha, S. Suwijn, P. Laguna, J. de la Rosette. A plea
for centralized care for ureteroscopy: results from a comparative study under
different conditions within the same center. J Endourol. 2011 Mar;25(3):425-9.
442.
T. Lopes, K. Sangam, P. Alken, B.S. Barroilhet, C. Saussine, L. Shi, J. de la Rosette;
Clinical Research Office of The Endourological Society Percutaneous
Nephrolithotomy Study Group. The Clinical Research Office of the Endourological
Society Percutaneous Nephrolithotomy Global Study: tract dilation comparisons in
5537 patients. J Endourol. 2011 May;25(5):755-62.
443.
S. Gravas, A. Bachmann, O. Reich, C.G. Roehrborn, P.J. Gilling, J. de La Rosette.
Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011
Apr;107(7):1030-43.
444.
C. Mamoulakis, A. Skolarikos, M. Schulze, C.M. Scoffone, J.J. Rassweiler, G.
Alivizatos, R.M. Scarpa, J.J. de la Rosette. Results from an international multicentre
double-blind randomized controlled trial on the perioperative efficacy and safety of
bipolar vs monopolar transurethral resection of the prostate. BJU Int. 2012
Jan;109(2):240-248.
445.
A. Yamaguchi, A. Skolarikos, N.P. Buchholz, G.B. Chomón, M. Grasso, P. Saba, S.
Nakada, J. de la Rosette; Clinical Research Office Of The Endourological Society.
Percutaneous Nephrolithotomy Study Group. Operating times and bleeding
complications in percutaneous nephrolithotomy: a comparison of tract dilation
methods in 5,537 patients in the Clinical Research Office of the Endourological
Society Percutaneous Nephrolithotomy Global Study. J Endourol. 2011
Jun;25(6):933-9.
Curriculum Vitae
40
J. de la Rosette
446.
K. Barwari, I.P. Kummerlin, F.J. Ten Kate, F. Algaba, I. Trias, H. Wijkstra, J.J. de la
Rosette, P. Laguna. What is the added value of combined core biopsy and fine
needle aspiration in the diagnostic process of renal tumours? World J Urol. 2011
May 28. [Epub ahead of print].
447.
M. Desai, A. De Lisa, B. Turna, J. Rioja, H. Walfridsson, A. D'Addessi, C. Wong,
J.J. de la Rosette On Behalf Of The Croes Pcnl Study Group. The clinical research
office of the endourological society percutaneous nephrolithotomy global study:
staghorn versus nonstaghorn stones. J Endourol. 2011 Aug;25(8):1263-8.
448.
B.W. Lagerveld, P. van Horssen, M.P. Laguna, J.P. van den Wijngaard, M. Siebes, H.
Wijkstra, J.J. de la Rosette, J.A. Spaan. Gradient changes in porcine renal arterial
vascular anatomy and blood flow after cryoablation. J Urol. 2011 Aug;186(2):681-6.
449.
C.H. van der Vlies, D.C. Olthof, O.M. van Delden, K.J. Ponsen, J.J. de la Rosette,
T.M. de Reijke, J.C. Goslings. Management of blunt renal injury in a level 1 trauma
centre in view of the European guidelines. Injury. 2011 Jul 8. [Epub ahead of print]
450.
P.J. Osther, H. Razvi, E. Liatsikos, T. Averch, A. Crisci, J.L. Garcia, A. Mandal A, J.
de la Rosette; Croes PCNL Study Group. Percutaneous nephrolithotomy among
patients with renal anomalies: patient characteristics and outcomes; a subgroup
analysis of the clinical research office of the endourological society global
percutaneous nephrolithotomy study. J Endourol. 2011 Oct;25(10):1627-32.
451.
K. Barwari, P.W. Beemster, M.N. Hew, H. Wijkstra, J. de la Rosette, M.P. Laguna.
Are there parameters that predict a nondiagnostic biopsy outcome taken during
laparoscopic-assisted cryoablation of small renal tumors? J Endourol. 2011
Sep;25(9):1463-8.
452.
E.C.C. Cauberg, J.J. de la Rosette, T.M. de Reijke. Emerging optical techniques in
advanced cystoscopy for bladder cancer diagnosis: A review of the current literature.
Indian J Urol. 2011 Apr;27(2):245-51.
453.
M. Smeenge, M. Mischi, M.P. Laguna Pes, J.J. de la Rosette, H. Wijkstra.
Novelcontrast-enhanced ultrasound imaging in prostate cancer. World J Urol. 2011
Oct;29(5):581-7.
454.
E.C. Cauberg, C.Y. Nio, J.J. de la Rosette, M.P. Laguna, T.M. de Reijke. Computed
tomography-urography for upper urinary tract imaging: is it required for all patients
who present with hematuria? J Endourol. 2011 Nov;25(11):1733-40.
455.
M.C. Rassweiler, C. Mamoulakis, H.G. Kenngott, J. Rassweiler, J. de la Rosette,
M.P. Laguna. Classification and detection of errors in minimally invasive surgery. J
Endourol. 2011 Nov;25(11):1713-21.
456.
K. Barwari, D.M. De Bruin, D.J. Faber, T.G. Van Leeuwen, J.J. de La Rosette,
M.P. Laguna. New optical diagnostic tools in renal cell cancer. Minerva Urol Nefrol.
2011 Sep;63(3):213-25.
457.
J.G. Valdivia, R.M. Scarpa, M. Duvdevani, A.J. Gross, R.B. Nadler, K. Nutahara, J.J.
de la Rosette; Croes PCNL Study Group. Supine versus prone position during
percutaneous nephrolithotomy: a report from the clinical research office of the
endourological society percutaneous nephrolithotomy global study. J Endourol.
2011 Oct;25(10):1619-25.
Curriculum Vitae
41
J. de la Rosette
2012:
458.
S. Gravas, V. Tzortzis, S.I. de la Riva, P. Laguna, J. de la Rosette. Focal therapy for
prostate cancer: patient selection and evaluation. Expert Rev Anticancer Ther. 2012
Jan;12(1):77-86.
459.
K. Barwari, J. de La Rosette, P. Laguna. The penetration of renal mass biopsy in
daily practice: A survey among urologists. J Endourol. 2011 Dec 27. [Epub ahead of
print]
Curriculum Vitae
42
J. de la Rosette

Jean de la Rosette, MD

Transcription

Similar documents

prostaatkanker

12 Urogenitale problemen

Bacteriële urineweginfecties bij adolescenten en

Syllabus PAOKC-cursus Klinische Chemie en Laboratoriumgeneeskunde Tumormarkers bij solide tumoren

Aangepaste richtlijn Benigne Paroxysmale - Med-Info

Hematurie - Kwaliteitskoepel

Richtlijn Urine-incontinentie bij vrouwen